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Abstract 
There are a number of mechanisms involved in producing a diversity of 
antibodies including multiple germline genes, somatic gene rearrangement, somatic 
hypermutation and combinatorial association. By the process of somatic 
hypermutation, one immunoglobulin gene in the germline can be mutated to produce 
many different genes in B cells. In chapter 2, this process is characterized. It was 
found that phosphorylcholine binding antibodies are encoded by one germline VH 
gene segment. In B cells, this VH gene segment may have extensive point 
mutations, many of which are silent, indicating the presence of some somatic 
hypermutational mechanism. Only the VH gene was found to be mutated indicating 
that the mutational mechanism was specific for V H genes. 
One way to study somatic immunoglobulin gene rearrangements, presented in 
chapter 3, might be to characterize rearrangements which are not easily 
explained. Immunoglobulin gene rearrangement was thought to exclusively involve 
immunoglobulin genes. However, some immunoglobulin genes can reproducibly 
rearrange with other DNA sequences. Insight into the basis of these 
rearrangements was uncovered by identifying the chromosomal origin of the non-
immunoglobulin rearranging DNA. This DNA originated on chromosome 15 whereas 
the immunoglobulin gene originated on chromosome 12. The juxtaposition of these 
sequences is common in plasmacytomas but rare or absent in normal B cells 
suggesting that it is involved in tumorigenesis. For example, it may be that 
aberrant immunoglobulin rearrangements can activate a cellular oncogene resulting 
in a plasmacytoma. This possiblity was supported by results from other laboratories 
when it was found that the non-immunoglobulin rearranging DNA contained the 
cellular homologue of the myc oncogene. 
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To understand lymphocyte tumorigenesis, it would be useful to understand 
the function of the c-myc gene product in normal and transformed cells. One way 
to begin is to determine which types of cells express the c-myc gene. This 
approach was employed in chapter 5 and it was found that the c-myc gene is 
expressed in dividing, but not resting, lymphocytes. One possible function for the 
c-myc gene product is that it functions in cellular proliferation. 
Another way to study the function of the c-myc gene product would be to 
prevent expression of the rearranged c-myc gene in plasmacytomas. For example, 
it may be possible to inhibit the synthesis of the c-myc gene product by antisense c-
myc RNA. If the antisense RNA can hybridize to the c-myc RNA in vivo, synthesis 
of myc protein may be prevented. A test case, in which antisense TK RNA is used 
to inhibit TK expression, is presented in chapter 6. In L cells, high levels of 
antisense TK RNA expression were capable of inhibiting TK activity. The 
mechanism of inhibition involves RNA:RNA hybridization since double stranded 
RNA was formed. If this test case can be applied to other instances, it may be 
possible to use antisense RNA to inhibit the synthesis of a particular gene product 
and thus study its cellular function. 
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About ten years ago, it became possible to isolate genes from higher 
eukaryotes as molecular clones. Of the universe of genes, what are the criteria for 
choosing which ones to study? What are the technical limitations governing which 
experimental approaches will yield fruitful information? This introduction outlines 
some of the ways in which genes from higher eukaryotes, especially mammals, have 
been studied at the molecular level. 
One general approach is to isolate molecular clones of genes which encode 
well studied proteins. For example, the genes encoding beta-globin, histone and the 
immunoglobulin lambda chain were among the first molecular clones to be 
identified from higher eukaryotes (Maniatis et al., 1976; Goldberg and Hogness, 
pers. comm. 1978; Tonegawa et al., l 977). The fact that these genes are 
abundantly expressed in certain cells simplified their isolation as cDNA clones. 
Once isolated, questions could be answered regarding their structure, expression 
and evolution. 
An ever expanding array of genes can now be isolated as molecular clones 
including genes whose mRNA and gene product are present in scarce quantities. 
Eventually, it may be possible to isolate molecular clones of genes for the vast 
majority of proteins with identified functions. For example, in the microchemical 
facility, it is planned to routinely sequence trace quantities of proteins and, from 
this data, to synthesize nucleic acid probes to enable the cloning of their genes 
(Hunkapiller et al., 1984). The bottleneck of scientific advancement may have 
shifted, from isolation of molecular clones, which is now becoming routine, to the 
biochemical identification of proteins with a given function, which is becoming 
more complex. 
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Another approach is to study the molecular genetics of genes which encode 
unidentified proteins. Such an approach is complementary to the one discussed 
above since biochemical analysis remains difficult or impossible in many cases. Of 
particular interest is the question of how one might study the cellular function of a 
gene from a higher eukaryote starting only with a molecular clone. In chapter 3, a 
molecular clone of a rearranged c-myc gene was isolated from a murine 
plasmacytoma. One pressing question was to determine the role of this oncogene in 
B lymphocyte development and tumorigenesis. At the time, practically nothing was 
known about the c-myc protein or its function. Since cases like this are becoming 
more frequent, it would be instructive to discuss some of the available 
experimental avenues. 
Gene expression which is regulated in a specific way would show when that 
gene functions and might also suggest the nature of that function. For example, in 
chapter 5, it was found that c-myc expression correlated with cellular proliferation 
suggesting that it may be involved in growth control. In other instances, genes 
specific to neurons have been studied (Sutcliffe et al., 1983; Anderson and Axel, 
pers. comm.) as well as those which are specific to T lymophocytes (Hedrick et al., 
l 984a; Yanagai et al., 1984). These genes may be involved in neural or immune 
function respectively. 
In many cases, availability of a molecular clone of a gene can assist 
biochemical analysis of its gene product. In some cases, one might even begin a 
biochemical analysis of previously unidentified proteins. For example, using 
information obtained from molecular clones of the Ubx gene, which is encoded in 
the bi thorax complex in Drosophila melanogaster, antisera specific to its protein 
product were prepared (White and Wilcox, 1985; Beachy et al., 1985). 
Immunocytochemical studies using these antisera suggested that this protein is 
localized to the nucleus. The possibility that the Ubx protein functions in the 
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nucleus enables one to make educated guesses as to its function, including its 
involvement in regulating gene expression. 
It is also possible to employ molecular clones to specifically alter in vivo 
gene expression. Gene expression can be increased using DNA mediated gene 
transfer; gene activity can be decreased using antibodies or antisense RNA. 
Molecular approaches such as these may be especially useful in those cases which 
are not easily amenable to classical genetics. 
Using DNA mediated gene transfer, DNA can be introduced into mammalian 
cells and the newly introduced genes can be expressed (Wigler et al., l 977). Gene 
transfer has a multitude of uses one of which is to introduce molecular clones into 
cells and, from the resulting phenotype, to deduce the function of the encoded gene 
product. However, this approach is limited in that it requires that the gene of 
interest have a dominant effect. There are many genes for which this might not be 
the case. Some genes are expressed constitutively so that introduction of extra 
copies of these genes, by gene transfer, may not cause a change in cellular 
behavior, even if the newly introduced genes are overexpressed. Also, some genes 
only function when expressed in concert with other genes. For example, they may 
participate in a pathway or the functional complex may be composed of several 
proteins. In these cases, expression of one gene would not be effective in lieu of 
expression from other genes in the pathway or the complex. Thus, there may be 
many cases in which the use of gene transfer to study gene function may be 
fruitless. 
A complementary approach is to study the effect of diminished gene 
activity. One possibility is to employ antibodies which can bind and neutralize a 
particular gene product in vivo (Mabuchi and Okuno, 1977; Yamaizumi et al., 1978; 
Antman and Livingstone, 1980; Lin and Feramisco, 1981; Burke and Warren, 1984). 
For example, in early frog embryos, microinjection of mRNA encoding anti-gap 
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junction antibodies caused certain cellular lineages to fail to develop suggesting 
that intercellular communication via gap junctions is crucial for early 
development. In using antibodies in this way, the following points are relevant. 
Antibodies may be compartmentalized when introduced into cells and therefore 
may not bind proteins present in other cellular compartments. Also, introduction of 
antibodies into one or a few cells precludes biochemical analysis of a large 
population of cells. 
Another way to reduce gene activity is to use antisense RNA. If the coding 
region of a gene is inverted, the opposite strand of DNA is transcribed resulting in 
complementary or antisense RNA. Potentially, this RNA can hybridize to sense 
RNA in vivo and prevent translation. There are precedents in E. coli which suggest 
that this may be so. Replication of the Col El plasmid, which requires an RNA 
primer, is regulated by antisense RNA (Tomizawa et al., 1981; Tomizawa, 1984). 
RNA complementary to the primer is formed by transcription of the noncoding 
DNA strand. Plasmids which produce this antisense RNA are capable of inhibiting 
replication in trans suggesting that hybridization of antisense RNA with primer 
RNA has interfered with replication. Second, the transposase gene from ISlO can 
be bidirectionally transcribed forming sense and antisense RNA (Simons and 
Kleckner, 1983). The presence of antisense RNA inhibits transposase expression. 
Third, high osmotic pressure induces the expression of OMP C mRNA and antisense 
OMP F RNA (Mizuno et al., 1984). As a result, OMP F expression is reduced. In 
these last two examples, it appears that antisense RNA is capable of hybridizing to 
sense RNA and thus preventing protein synthesis. 
In eukaryotes, a small nuclear RNA, U 1, has sequences complementary to 
those found at the 5' ends of intrans. It is thought that base pairing between U 1 and 
pre-mRNA is involved in RNA splicing (Lerner et al., 1980; Rogers and Wall, 
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1980). In this example, double stranded RNA is a requirement for, rather than an 
inhibitor of, biological function. 
These examples suggest that, under certain circumstances, antisense RNA 
can hybridize to sense RNA in vivo. In at least some cases, hybridization may be 
affected by protein interaction and may not be due solely to binding of 
complementary nucleic acids (Tomizawa and Som, 1984). Nevertheless, these 
precedents suggest that antisense RNA could be used to specifically reduce gene 
activity. This possibility was first tested by synthesizing antisense oligonucleotides 
and observing their effect on corresponding sense RNAs. Oligonucleotides 
complementary to the E.coli 16S ribosomal RNA, at the point where it binds the 
Shine-Dalgarno sequence, were observed to inhibit translation in vitro and colony 
formation in vivo (Jayaraman et al., 1981; Taniguchi and Weissman, 1978). One 
interpretation of these results is that oligonucleotide binding prevented the l 6S 
ribosomal RNA from initiating translation. Similarly, oligonucleotides 
complementary to a short region from Rous sarcoma virus were capable of 
inhibiting translation in vitro and mammalian cell growth and transformation in 
vivo (Stephenson and Zamecnik, 1978; Zamecnik and Stephenson, 1978). 
Antisense genes have been constructed which produce complementary RNA 
capable of specifically reducing gene activity. In E. coli, genes which express 
antisense OMP A, OMP C, LPP and lac Z RNAs have been studied (Coleman et al., 
1984, Pestka et al., 1984). All of these genes were expressed from the lac Z 
promoter and, when induced, were capable of reducing gene activity from the 
corresponding sense genes as much as twenty fold. Different antisense genes were 
effective to varying extents. Although in some aspects this variability is not well 
understood, it seems important for the antisense RNA to cover the AUG start 
codon. This observation suggests that antisense RNA impedes the initiation of 
translation. These important experiments suggest that antisense RNA may 
potentially affect a broad range of bacterial genes. 
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In frog oocytes, microinjection of antisense beta-globin RNA was capable of 
reducing the synthesis of beta-globin from microinjected mRNA (Melton, 1985). 
Since double stranded beta-globin RNA is detected, RNA:RNA hybridization is 
almost certainly involved. Experimental approaches such as this may be useful to 
study the function of genes which are expressed in early embryogenesis. However, 
the presence of antisense RNA, and thus the effect of reduced gene activity, is only 
transient. Therefore, this approach may not be applicable for those cellular 
phenotypes which can only be observed over a period of time. Furthermore, since 
antisense RNA inhibits protein synthesis rather than the gene product itself, the 
block in translation must last long enough for any preexisting protein to either 
dilute or degrade. Otherwise, the ef feet of antisense RNA will disappear before 
the amount of gene product diminishes significantly. Finally, as with the antibody 
approach, microinjection of individual cells requires that any effect be apparent in 
small numbers of cells. 
Elegant work by Izant and Weintraub (1984) has shown that antisense RNA 
can function to reduce gene activity in mouse L cells. Antisense thymidine kinase 
(TK) RNA, produced by either microinjected or chromosomal antisense genes, can 
transiently inhibit the expression of a microinjected TK gene. Although 
preliminary, this experiment suggests that the study of mammalian gene function 
with antisense genes may be possible. However, to realize this possibility, it is 
important to show that antisense RNA can permanently reduce gene activity from 
endogenous as well as microinjected genes. Since TK activity was assayed 
transiently, it is not known whether the effect of antisense RNA is transient or 
permanent. Furthermore, whereas the activity of microinjected TK genes is 
significantly reduced by antisense RNA, the activity of chromosomally integrated 
TK genes is not (J. Izant and H. Weintraub, pers. comm.). Although the reason for 
this difference is unknown, it severely limits this type of approach. 
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In chapter 6, the activity of a TK gene, integrated into the genome of a 
mouse L cell, is permanently reduced by the expression of antisense TK RNA. In 
this study, a high level of antisense RNA was necessary to stably reduce TK gene 
activity. This high level was obtained by expressing antisense TK sequences with 
sense dihydrofolate reductase (DHFR) sequences as part of a chimeric transcript. 
Overexpression of DHFR can be selected with the drug methotrexate which, in this 
instance, also results in overexpression of antisense TK RNA. Thus, at least in 
tissue culture cells, it may be possible to observe the effect of diminished activity 
of any gene for which a molecular clone is available. In conjunction with DNA 
mediated gene transfer, antisense RNA could be used to control the level of 
activity for a gene of interest. In a sense, such an approach mimics that of 
classical genetics in which mutations resulting in a gain or a loss of function are 
analyzed. One advantage of a molecular approach over a genetic approach is that, 
in the former, gene expression can be altered in a precisely controlled fashion. For 
example, gene activity might be conditionally reduced by expressing antisense RNA 
from an inducible promoter. Also, some transcription units produce multiple 
mRNAs. In these cases, appropriate antisense RNAs could be used to hybridize to a 
specific mRNA and could thus help discern the function of the particular protein 
encoded in that mRNA. 
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Summary 
The immune response to phosphorylcholine in 
BALB / c mice has been well characterized. Amino 
acid sequence analyses of heavy-chain variable (VH) 
regions from 19 myeloma and hybridoma immuno-
globulins binding phosphorylcholine show that 10 
are identical (the prototype T15 VH sequence) and 
9 are distinct variants differing by one to eight 
residues . A T15 VH DNA probe was used to isolate 
four closely related members of the T15 VH gene 
family , including one encoding the T15 VH se-
quence, from a sperm genomic library. A compari-
son of the protein and germline VH sequences sug-
gested that most of the immune response to phos-
phorylcholine is derived from the T15 germline VH 
gene segment. The variant heavy chains from the 
M167 and M603 a immunoglobulins differ in their 
VH protein sequences from T15 by eight and three 
residues, respectively . We analyzed the somatic 
variability in and around the coding regions of these 
two variant VH genes by comparing them with the 
corresponding regions of the appropriate germline 
gene segments. The somatic variation has three 
properties: it is extensive and is found in flanking 
as well as coding sequences (for example, at least 
44 substitutions for the M167 sequence and 10 
substitutions for the M603 sequence); in the coding 
regions, it includes many silent as well as replace-
ment substitutions; and it is focal in nature and 
centered around the rearranged VH genes. Although 
the mutations extend into the neighboring upstream 
and downstream flanking sequences, sequences 
approximately 5 kb upstream and downstream from 
the VH genes show no substitutions. Moreover, the 
associated heavy-chain constant genes (C..) from 
both variant a genes are unaltered, indicating that 
a closely linked and coexpressed gene is unmu-
tated. We conclude that this somatic variation is 
generated by a special hypermutational mechanism 
highly localized in its site of execution and highly 
restricted in its time of operation during B-cell de-
velopment. 
Introduction 
The somatic variation of antibody genes plays an 
integral role in permitting a vertebrate such as the 
mouse to synthesize perhaps 1 08 distinct types of 
• Present address: Labora tory of Immunology, National Institute of 
Allergy and Infectious Diseases. National Institutes of Health. Be-
thesda. Maryland 20205. 
antibody molecules. We analyze the diversity patterns 
generated by a special somatic mutational mecha-
nism. 
The antibody molecule is comprised of light (L) and 
heavy (H) chains, wh ich fold into variable (V) domains 
that bind antigen and constant (C) domains that en-
code effector functions (for a review see Early and 
Hood, 1981 ). In turn , the variable regions of the Land 
the H chains from different immunoglobulins exhibit 
three areas of extreme variability termed the hyper-
variable segments (Wu and Kabat. 1970; Capra and 
Kehoe, 1974), which fold to constitute the walls of the 
antigen-binding site (Amzel et al., 1974). 
lmmunoglobulins are encoded by three families of 
genes-two for L chains, >-. and K, and one for H 
chains . The V regions are encoded by gene segments 
separated from one another in the germline-VL and 
JL (joining) as well as VH . D (diversity) and JH-which 
are rearranged and joined during 8-cell differentiation 
to generate VL and VH genes, respectively (Brack et 
al. , 1978; Sakano et al., 1979; Seidman et al., 1979; 
Early et al., 1980; Saka no et al. , 1980). The C regions 
are encoded by separate genes. In the mouse , there 
are eight CH genes which encode the various classes 
and subclasses of immunoglobulins (for example, C,. -
lgM, C,,-lgA, and so forth) . Initially , the VH gene is 
always associated with the C" gene, and lgM mole-
cules are expressed (Cooper et al. , 1976; Raff, 1976). 
Subsequently, antigen may trigger B-cell differentia-
tion and the second type of DNA rearrangement, the 
class switch, occurs when the C,, gene is replaced by 
another CH gene, and th is results in the expression of 
a different immunoglobulin class (Davis et al., 1980a; 
Kataoka et al. , 1980; Lawton et al., 1980; Maki et al., 
1980). 
A somatic mutation mechanism has been postulated 
to explain the diversity scattered throughout certain 
v~ (Weigert et al. , 1970; Weigert and Riblet , 1976; 
Bernard et al. , 1978; Brack et al., 1978), V, (Valbuena 
et al., 1978; Weigert et al., 1 978; Pech et al. , 1981 ), 
and VH (Hood et al. , 1976; Bothwell et al., 1981; 
Crews et al. , 1981; Gearhart et al. , 1981) genes. We 
have studied the role somatic mutation plays in the 
immune response to the simple hapten , phosphoryl-
choline. Protein sequencing studies of VH regions 
(Hood et al., 1976; Gearhart et al., 1981) combined 
with DNA sequencing studies of germline VH genes 
(Crews et al., 1 981) have demonstrated several fea-
tures of somatic mutation in the phosphorylcholine 
system. First , ten of nineteen VH segments, that por-
tion of the VH region encoded by the VH gene segment, 
have identical protein sequences (this sequence is 
denoted T1 5), whereas the nine remaining variants 
are all unique and differ from the prototype T1 5 se-
quence by one to eight amino acid residues. Second, 
only four germline VH gene segments closely homol-
ogous to a T15 VH gene probe were found in the 
BALB/ c genome. One germline VH gene encodes the 
Cell 
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T15 sequence . All nine variant VH segments appear to 
arise from the germline T1 5 VH gene segment because 
the variants are related much more closely in se-
quence to the T1 5 VH gene segment than to any one 
of the other three T15-like VH gene segments. Thus it 
appears that the entire immune response to phospho-
rylcholine is derived from a single germline VH gene 
· segment and that somatic mutation occurs frequently 
(9 / 19 examples). Third. somatic mutation correlates 
with the class switch because the variant VH regions 
only appear associated with immunoglobulins of the 
lgG or lgA class. but not with immunoglobulins of the 
initially expressed lgM class. 
Since we had analyzed the entire family of germline 
T1 5 VH genes and many protein VH regions . our next 
approach was to clone and sequence two variant T1 5 
VH genes. M167 and M603, whose VH segments differ 
at the protein level from T15 by eight and three 
residues. respectively . We report the cloning and se-
quence analysis of the VH gene from the phosphoryl-
choline-binding lg A myeloma M 167. The M 167 VH 
gene . its flanking regions and the 5' portion of its C .. 
gene were compared to the corresponding regions of 
germline (sperm) DNA and to a second variant phos-
phorylcholine-binding lgA myeloma M603, which we 
had previously cloned (Early et al., 1980). We show 
that the M 167 and M603 VH genes are derived from 
the germline T15 VH gene segment. The somatic var-
iation is extensive and is sharply localized in and 
around the rearranged VH genes. We conclude that 
the somatic variation is produced by a special hyper-
mutational mechanism . 
Results and Discussion 
Isolation of the M167 VH Gene 
Because the four VH gene segments of the T15 gene 
family crosshybridize strongly with the T1 5 VH probe, 
a C,, probe was employed to isolate the rearranged 
M167 VH gene since the M167 tumor synthe-
sizes an immunoglobulin of the lgA class. Using this 
probe in a Southern blot analysis of Eco RI-cleaved 
M167 DNA. two major bands were observed (13 kb, 
4.6 kb; Figure 1 A) . The 13 kb band represents a 
nonproductively rearranged c. gene (K . Calame and 
S. Kim, unpublished data), and the 4.6 kb band was 
the rearranged and expressed M 1 67 C. gene (see 
below). 
A library of 2.0 x 106 phage was constructed from 
M167 myeloma tumor DNA partially digested with Hae 
111 or Alu I and inserted into the vector Charon 4A. The 
library was screened using a C. probe, and five clones 
were obtained. One clone was representative of the 
13 kb Eco RI band (data not shown). The remaining 
four clones contained a 4 .6 kb Eco RI band. Southern 
blot, restriction map and DNA sequence analyses 
indicated that three of these clones also contained the 
















Figure 1. Southern Blot Analyses of Ml 67 and Liver DNAs 
Approximately 15 µg of DNA was digested with Eco RI , fractionated 
on a 0.8% agarose gel , transferred to nitrocellulose paper and hy-
bridized with a 5' c. probe constructed by subcloning the 5.1 kb Eco 
RI fragment from ChM603a6 into pBR322 (A) or with a 5' VH probe 
constructed by subcloning the 1 .4 kb Barn HI fragment from 
ChM167a10 into pBR322 (8). The faint band in A migrating at 9.5 kb 
comigrates with the germline C. gene and presumably originates from 
host-cell DNA contamination. The difference in band size shown in B 
was corroborated by a Southern blot analysis of Hind Ill-digested 
DNAs in which liver DNA showed a single band at 7.0 kb and M167 
DNA shows a single band at 4 .0 kb using the same 5' VH probe (data 
not shown). 
map data derived from one clone, ChM 167 a:10, con-
taining the rearranged M167 VH gene are presented 
in Figure 2 . 
The M167 and M603 VH Genes Are Derived from 
the Germline T15 VH Gene Segment 
The amino acid sequences encoded by the four genes 
of the T15 VH gene family do not include the M167 or 
M603 VH sequences, although the two myeloma se-
quences are much closer to the T1 5 sequence than 
to the three other T15-like sequences. Furthermore, 
restriction map, heteroduplex and DNA sequence 
analyses (see below) establish that the 5' flanking 
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Figure 2 . Restriction Maps and Sequence Strategies for the lmmunoglobulin Genomic Clones 
(A) Restriction maps of various T15-related clones. The M167 clone (ChM167a10), the M603 clone (ChM603a6}, the germline T15 V" clone (.X. V,}, 
the germline C, gene (ChSpµ27} and the germline C. gene (ChSpa29} are presented. The XV,, ChM167a10 and ChM603a6 clones have identical 
Eco Al, Xba I, Hind Ill , and Barn HI sites upstream from the Vtt gene segment (see Davis et al., 1980a; Crews et al. , 1981 }. The regions of each 
clone sequenced in this report are indicated by a shaded box above the restriction map. Sequences reported previously are indicated by an open 
box (Early et al. , 1980; Davis et al. , 1980b; Crews et al. , 1981 }. The regions used as probes in Figure 1 are indicated by a line below the 
restriction map. A: Ava II . B: Barn HI. Bg : Bgl II. F: Fnu4HI. H: Hint I. Hd: Hind Ill . Hh: Hha I. A: Eco Al. X: Xba I. Xh: Xho I. a: 5' flanking Vtt 
sequence. b: V" sequence. c: 3 ' flanking Vtt sequence. d: switch sequence . e: c. sequence. 
(B) Sequencing strateg ies. Arrows ending at a restriction site indicate 3' end-labeling and arrows beginning at a restriction site indicate 5' end-
labeling . The antisense strand of the M167 switch site was sequenced by 5' end-labeling at the Sau 3A site at position 357 in Figure 3. The 
antisense strand of the germline T15 V" gene segment was sequenced by 5' end-labeling at the Hint I site at position 276 in Figure 3. Expanded 
maps of the M167 V" region and the germline JH region, as well as their sequencing strategies, are depicted. 
reg ions of both the M 167 and the M603 VH genes are 
identical , apart from some somatic variation, to the 5' 
flanking region of the germline T1 5 VH gene segment, 
but are distinct from the 5' flanking regions of the 
other three T1 5-like VH gene segments (Figure 3, and 
data not shown). The above comparisons show that 
the M167 and M603 VH genes are related much more 
closely to the germline T15 VH gene segment than to 
the other VH gene segments in the T15-like VH gene 
family. 
Southern blot analysis indicated that the 5' flanking 
regions of the M 167 and M603 VH genes arose from 
a germline VH gene segment originally located on a 
7.8 kb Eco Al fragment. When Eco RI-restricted DNA 
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was blotted and probed with a 1 .4 kb Barn HI fragment 
derived from the 5' flanking side of the M 167 VH gene , 
liver DNA revealed a single band. 7.8 kb , which co-
migrated with the Eco RI fragment containing the T1 5 
VH gene segment from the clone 'AV , (Crews et al., 
1981 ). whereas M 167 DNA revealed a single band, 
7.2 kb, which comigrated with the Eco RI fragment 
conta in ing the M 167 VH gene from the clone 
ChM 167n 1 0 (Figure 1 8 and data not shown). These 
observations suggest that the 7.8 kb germline T15 VH 
Eco RI fragment was rearranged in the tumor line to 
yield a 7.2 kb M167 VH gene . Since the 5' flanking 
regions of the M603 and M 167 VH genes are essen-
tially identical by all criteria tested, it can be inferred 
that the M603 VH gene also arose from a germl ine 7.8 
kb Eco RI fragment. 
Three lines of evidence indicate that only one T15-
like VH gene segment on a 7.8 kb Eco RI fragment is 
contained in the BALB / c genome . First. if there were 
mult iple VH genes on fragments 7 .8 kb in length. we 
would not expect all of them to be identically rear-
ranged. However, Figure 2 indicates that the 7 .8 kb 
band is missing in M167 DNA and is replaced by a 
7.2 kb band . This observation impl ies that the T15 VH 
gene on the other heavy-chain chromosome in the 
M 167 tumor cell line has been deleted . Second , four 
independent clones containing the 7.8 kb Eco RI 
fragment have been sequenced and , in each case , 
the VH gene segments encoded the prototype T1 5 
sequence rather than the variant M603 or M 1 67 se-
quences (Early et al ., 1980; Crews et al., 1981 ; S. 
Crews, unpublished observations). It is therefore sta-
tistically improbable that there is more than one VH 
gene segment on a 7.8 kb Eco RI fragment. Third , as 
mentioned above , the rearranged M 167 and M603 VH 
genes and the germline T1 5 VH gene segments have 
essentially identical 5' flanking regions by restriction 
map, heteroduplex and DNA sequence analyses. This 
flanking sequence identity suggests that the M 167 
and M603 VH genes are derived from the germline 
T1 5 VH gene segment. 
The M167 and M603 VH Genes Appear to Have 
Arisen by Somatic Mutation and Not from Myeloma 
Artifacts or Genetic Polymorphism 
Two trivial explanations for the origin of the variant 
M167 and M603 sequences are mutational drift in the 
myeloma cell lines and genetic polymorphisms in the 
inbred BALB / c strain of mice. Mutational drift in the 
myeloma cell lines appears improbable for several 
reasons . First , it is not clear why the variants (for 
example, M 167) would have a selective advantage 
over the wild-type cells , presumably T1 5, since the 
extensive amino acid differences observed (eight for 
M 167) would require multiple rounds of mutation and 
selection . Second , one particular myeloma cell line , 
T15 , has maintained its VH amino acid sequence over 
a span of some ten years, indicating that in thi s 
myeloma cell line little or no mutation has occurred 
(L. Hood , unpublished observation) . Th ird. many 
hybridoma cell lines that have been passaged for only 
short periods exhibit variant VH sequences, indicating 
that mutations probably arose in functional 8 cells 
before cell fusion (Gearhart et al., 1981 ). Finally , when 
flank ing sequences 5 kb upstream and 5 kb down-
stream from the M 167 and M603 VH genes are com-
pared with their germline counterparts , no mutations 
are observed in more than 1 000 bp compared (Figure 
3) . If random mutations were widespread in the mye-
loma cell lines and not subject to selection, these 
flanking regions would be expected to exhibit muta-
tions to the same extent as those seen in the coding 
region . Thus we conclude that the variations seen in 
the M167 and M603 cell lines are not a consequence 
of mutational drift in the myeloma cell lines. 
It is improbable that genetic polymorphism in differ-
ing BALB / c mice can account for the variation seen 
between the M167, M603 and germline T15 VH gene 
segments. First , if this hypothesis were correct, the 
difference between the putative M167 and T15 VH 
alleles (44 substitutions in 1 054 bases compared [see 
below]) would be far greater than the polymorphism 
seen between the BALB/ c and C3H strains in the 
same area (0 / 301) (Kurosawa et al., 1981 ). Second , 
it is not clear why the polymorphic substitutions would 
localize themselves in and around the rearranged VH 
gene and not extend to its flanking regions (see be-
low). 
These data strongly suggest that the M167 and 
M603 VH genes are not present in the BALB / c ge-
nome and that the origin of the mutation cannot be 
due either to mutational drift in myeloma cell lines or 
to genetic polymorphism. Thus the M167 and M603 
VH genes are somatic variants of the germline T15 VH 
Figure 3 . A Comparison of Various Homologous Nucleotide Sequences from Somatic, M167 and M603. and Germline DNAs 
DNA sequences were determined by the method of Maxam and Gilbert (1980) . The germline sequence is always listed on top . Nucleotide identities 
are indicated by a line. nucleotide substitutions are denoted by the appropriate letter , insertions or deletions are indicated by a space and 
replacement substitutions are indicated by a box . Exons are indicated by the triplet spacing. The C .. exon codes for the hinge and CH2 regions . 
The 24 nucleotide deletion in the M 167 3' flanking V" region may be a cloning artifact since small deletions in the same area have appeared in the 
germline sequence reported by Gough and Bernard (1981) and in a clone derived from the myeloma Tl 5 (S. Kim. unpublished observations). The 
switch region for M 167 is shown . The S, site is identical to the M603 S, site. The S,, site occurs in a 30 nucleotide repeat often associated with 
a switching (Davis et al.. 1 980a). There are 142 bases between the S, and S .. sites, which are of unknown origin . The S .. sequence differs from that 
reported previously (Davis et al .. 1980b) at positions 206. 249. 270, 275 and 278 owing to previous errors in data transcription . The M603 VH . 
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Figure 4 . Mutations Occurring in and around Two Varian t T15 V,, Genes 
(A) The location of the nucleotide substitutions, insertions or deletions in the M 167 and M603 clones are indicated by a vertical line. The exact 
locations of the sequence regions shown are ind icated in Figure 2A . When the mutati ons are adjacent, the lines are moved apart until they are 
distinct. (B) The point mutations in the coding regions inc lude both silent (0) and amino ac id replacement (X) substi tut ions. 
gene segment. Let us now consider the nature of the 
mutational pattern that has been imposed on these 
two somatically derived VH genes. 
Somatic Variation Is Extensive and Localized in 
and around the Rearranged VH Gene 
To determine the extent and distribution of nucleotide 
substitutions in and around the variant VH genes, we 
compared the nucleotide sequences of the M 1 67 and 
_M603 VH genes and their flanking sequences, regions 
located 5 kb upstream and 5 kb downstream from the 
· VH genes, and portions of the 5' end of the C,, genes 
to their germline counterparts (Figure 3) . Figure 4A 
diagrammatically depicts the distribution and number 
of mutations scattered throughout these regions. 
The pattern of somatic variation in the variant VH 
genes exhibits several interesting characteristics. 
First , it is extensive. The M167 VH gene has 44 sub-
stitutions in the 1 054 nucleotides analyzed (3.8% 
variat ion) , wh ich includes the coding regions (L, VH 
and JH) as well as the adjacent flanking regions (a 
Portion of the 5'-untranslated region , the L-VH intron 
and a portion of the JH-Co intron) . We count sequence 
deletions or insertions as well as nucleotide changes 
as substitutions . Substitutions probably occur in the 
D-gene segment, although this cannot be verified until 
the germline M167 D-gene segment is isolated . The 
M603 VH gene shows fewer mutations with ten sub-
stitutions in 714 bp analyzed (1 .4% variation). Sec-
ond, the variation is sharply localized in and around 
the variant VH genes . A 200 bp sequence 2 kb to the 
3' side of the M167 VH gene has only two substitu-
tions, whereas a 200 bp sequence from the same 
region in the M603 VH gene has no substitutions. 
Moreover, 300-500 bp sequences 5 kb upstream and 
5 kb downstream from both the M167 and M603 VH 
genes have no substitutions at alL The rate of mutation 
2.3 kb downstream from the rearranged M167 and 
M603 VH genes is therefore significantly less than in 
and around the VH gene itself, and there appears to 
be no mutation at all 5 kb to either side of the VH 
genes. Finally, the 5' portion of the M167 and M603 
C,. genes show no substitutions, indicating that a 
closely linked and coexpressed gene is not subjected 
to somatic variation. Thus the somatic variability is 
localized in and around the rearranged VH genes. 
Third, many silent as well as replacement substitutions 
occur in the coding regions of the variant VH genes. 
(A silent substitution is a base change that does not 
change the amino acid residue encoded by a partic-
ular codon,) The M167 VH coding region differs from 
the germline T15 VH coding region by 14 nucleotides, 
and five of these are silent substitutions. The M603 
VH coding region differs by seven nucleotides, four of 
which are silent Thus, in the coding regions, silent 
mutations are almost as common as replacement sub-
stitutions. Finally, a detailed analysis of the types of 
base substitutions occurring in the variant M167 and 
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M603 VH genes does not shed any light on the mech-
anism of somatic variation (Table 1 ). For example, no 
particular base has a greater tendency to mutate than 
do the others. Transversions as well as transitions 
occur. Base changes occur about equally at all of the 
codon positions . However, two interesting points 
emerge from this analysis. First, the mutational mech-
anism is capable of generating small deletions and 
insertions as well as base substitutions (for example, 
eight deletions and insertions in M 167). This obser-
vation is surprising and somewhat disturbing because 
single base insertions or deletions in the coding region 
would alter the downstream reading frame of the VH 
gene. Second, about 50% of the mutations in the 
coding regions occur in hypervariable region 2 (10 / 
21 ), whereas this region accounts for only 18% of the 
VH gene segment. This concentration of variability 
probably reflects the result of selection for sequence 
variations in these regions. 
The Mechanism of Somatic Mutation 
Several patterns have emerged from this and other 
studies on the phosphorylcholine immune response 
that have interesting implications for the mechanism 
of somatic variation (Crews et al. , 1981; Gearhart et 
al. , 1981). 
First . a special mutational mechanism must be ca-
pable of generating extensive diversity-a 3 .8% nu-
cleotide substitution rate in the case of the M 167 VH 
gene and its adjacent flanking sequences. It appears 
improbable that mutational changes of this extent can 
arise solely by intense selection for variant sequences 
appearing at an ordinary mutational rate because of 
the number of mutations , their focal nature and the 
fact that 35 of 44 mutations are silent in the M167 VH 
gene and surrounding regions and, accordingly, can-
not be fixed by selection . Thus we conclude that some 
form of special hypermutational mechanism generates 
multiple substitutions, both silent and replacement , 
and the constellation of these substitutions is then 
selected presumably by virtue of increased antigen-
binding attinity, release from idiotype suppression or 
some other unidentified selective force (see Crews et 
al., 1981). 
Second , somatic mutation occurs in the vicinity of 
the rearranged VH gene and clearly diminishes as one 
moves away from the gene until the mutation is infre-
quent or nonexistent 4-5 kb away. Thus the hyper-
mutational mechanism is localized in and round the VH 
gene . The focal nature of the mutational mechanism 
suggests that it recognizes the rearranged VH gene . 
For example, rearranged V or J gene segments may 
be recognized by an enzyme which then cleaves a 
single DNA strand in or near the rearranged gene 
segment. Subsequently, repair of this strand may oc-
cur with errors. The error frequency presumably de-
clines as the distance from the cleavage site in-
creases. Indeed, since the Ca genes associated with 
M167 and M603 VH genes are not mutated, the mu-
tational mechanism appears specific for the rear-
ranged VH genes. A general mechanism of this sort 
was previously proposed by Brenner and Milstein 
(1967). 
Third , in the phosphorylcholine system there is a 
striking correlation between somatic mutation and the 
class switch (Gearhart et al., 1981 ). The V H regions 
associated with lgM (Cµ) molecules always have the 
germline T15 sequence, whereas the variant VH re-
gions always are associated with lgG (Cy) or lgA (C .. ) 
molecules that have undergone a class switch . Like-
wise, the VL regions from lgG or lgA molecules gen-
erally show variation, whereas the VL regions from lgM 
molecules do not. The somatic mutation mechanism 
is not obligatorily coupled to the class-switching 
mechanism because lgA molecules can have germline 
VH and VL regions (Gearhart et al., 1981 ). 
Table 1. Numbers of Transitions, Transversions, Insertions and Deletions in the M 167 and M603 VH Genes as Compared with the Germ line T15 
V" Gene Segment 
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There is one important caveat to our suggestion of 
a hypermutationai mechanism. Perhaps the M 167 VH 
gene has undergone extensive mutat ion in an atypical 
manner. We believe this is improbable for several 
reasons . First . if atypical mutations have occurred. 
why are they so sharply localized around the M 167 
vH gene? Second, the M603 VH gene also shows 
substitutions in its 3'-flanking sequence , although 
there are far fewer substitutions in this case. Clearly, 
an analysis of other variant VH genes differing by six 
or more residues from their germline counterparts 
should be ca rried out. 
Antibody diversity appears to arise in two stages of 
s-ce ll development. Germline gene segments are 
joined in a combinatorial fashion to generate a large 
baseline repertoire created independent of external 
antigenic stimulation. In addition. junctional somatic 
variation is generated at this early stage of B-cell 
differentiation by the flexible joining of the various 
gene segments (Max et al., 1979; Sakano et al., 1980; 
Weigert et al., 1980; Hood et al., 1981) that constitute 
the V gene . Subsequently , at a late stage in B-cell 
development, antigen may trigger B cells to undergo 
differentiation which leads to class switching and per-
haps to the activation of a special somatic hypermu-
tational mechanism. Thus antigen may trigger the 
generation of variants by somatic mutation in the VL 
and VH genes. It is attractive to postulate that antigen 
then selects those variant lymphocytes that have 
higher affinity antibody receptors for clonal expan-
sion, thus leading to the well known affinity maturation 
of the immune response. However, our analysis of the 
phosphorylcholine system demonstrates that variant 
immunoglobulins do not necessarily have higher affin-
ities for phosphorylcholine than do the germline anti-
bodies (Gearhart et al., 1981 ). This raises the possi-
bility that other forms of selection may operate in the 
vertebrate immune response (see Crews et al., 1981, 
for discussion). B cells at the early and late develop-
mental stages probably undergo their differentiation 
events in the central and peripheral lymphoid organs. 
respect ively (Baltimore , 1981 ). 
Experimental Procedures 
Construction and Screening of the M167 Library 
High molecular weight DNA from the M 167 myeloma cell line was 
prepared as described (Blin and Stafford . 1976). The DNA was 
digested partially with the restrict ion enzymes Hae Ill or Alu I. size-
fractionated on a 1 0% to 40°10 sucrose gradient. ligated to synthetic 
Eco RI linkers and inserted into the vector Charon 4A (Blattner et al. . 
1977; Maniatis et al.. 1978). The library was packaged in vitro by the 
Procedure of Hohn and Murray (1977) using the strains of Sternberg 
(1977) . The library was screened. before amplification. by the pro-
cedure of Benton and Davis (1977) using a 32P-labeled C .. probe 
constructed by subcloning the 5.1 kb Eco RI fragment from ChSpa6 
into the Eco RI site of pBR322 (see Figure 2) . 
Genomic Blot Hybridizations 
Myeloma DNAs were prepared by the method of Blin and Stafford 
(1976). Sperm DNA was a gift from T. Hunkapiller . and liver DNA was 
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a gift from M. Steinmetz . Approximately 15 µg of DNA was digested 
to completion with the appropriate restriction enzyme. size- fraction-
ated on horizontal 0 .8°'o agarose gels. and transferred to nitrocellu-
lose paper by the method of Southern (1975). Hybridizations were 
carried out in 1.0 M NaCl , 0.2 M Tris-HCI (pH , 7.8), 10 X Denhardt s 
(Denhardt. 1966). 0.1 % SOS. 0 .1 % sodium pyrophosphate. 50 µg / 
ml poly(rA), 20 µg / ml denatured salmon sperm, and labeled probe at 
a concentration of 1 O' cpm of hybridizable sequence per millil iter at 
68°C for 12 hr with agitation. The blots were washed twice in 1 .0 M 
NaCl . 5x Denhard t"s. 0 .5 M Tris-HCI , 0 .1 % SOS. 0 . t % sod ium 
pyrophosphate for 30 min at 68 °C, and then twice in 0 .15 M NaCl, 
0 .015 M sodium cit rat e, 0 .1 ~o SOS. 0 .1 % sodium pyrophosphate for 
30 min at 68 °C. Autcradiography was accomplished at - 70 ' C with 
an intensifying screen . 
DNA Sequencing 
Restriction fragments were 5' endlabeled with 32P-y-ATP and poly-
nucleotide kinase after treatment with bacterial alkaline phosphatase. 
DNA polymerase I (large fragment) and 32P-a-dNTPs allowed 3' 
endlabel1ng . The method of Maxam and Gilbert (1980) as modified 
by Smith and Calvo (1980) was employed for DNA sequence analysis. 
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The function of somatic hypermutation 
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One of the most interesting problems of immunology has been to understand 
how antigen recognition occurs. Classic studies by Landsteiner proved that the 
immune system is capable of distinguishing subtle differences in chemical structure 
suggesting that the total number of antigens which can be specifically recognized 
must be astronomical. In the humoral arm of the immune system, antigen 
recognition is accomplished with immunoglobulins. Thus, the key issue concerns 
how a specific immunoglobulin can be produced with the ability to bind a single 
antigen from an enormous array of potential antigens. 
One explanation is that a large number of immunoglobulins are made so that 
at least one of them is capable of binding essentially any chemical molecule. Those 
B cells which produce appropriate immunoglobulins are induced to expand clonally. 
Thus the response to antigen is amplified and immunity is conferred. A 
problematical aspect of this clonal selection model is that the number of potential 
antigens, and thus the number of required immunoglobulins, are both astronomical. 
The molecular genetics of antibody genes have been well studied and it is clear that 
there are mechanisms for generating a large number of different immunoglobulins 
from a limited genome (for a review, see Tonegawa, 1983). A separate issue is 
whether the physical size of a mouse is sufficient to house enough B cells to express 
all of these immunoglobulins. There are less than 109 lymphocytes in a mouse; the 
immunoglobulin repertoire cannot exceed this maximum at any one time. 
A second explanation is that antigen causes preimmune antibodies to change 
their binding specificities resulting in tighter binding. One advantage of this 
instructionist model is that the postulated size of the immunoglobulin repertoire is 
much smaller. However, a disadvantage is that, a priori, it is unclear how antigen 
can induce changes in binding specificity. 
How does somatic hypermutation fit into the framework of antigen 
recognition described above? Somatic hypermutation is thought to occur as follows 
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(Gearhart et al., 1979; Crews et al., 1980; Kim et al., 1980). After the formation of 
a baseline repertoire, introduction of antigen causes appropriate B cells to 
selectively proliferate. As they do so, antibody genes undergo hypermutation and 
express receptors with either improved or lessened binding affinities. A second 
round of immunological selection can then select for B cells which bind antigen 
more tightly. Thus, hypermutation usually correlates with antibody class; IgG, but 
not IgM, antibodies are mutated (Gearhart et al., 1979; Bothwell et al., 1981 ). 
However, there are some exceptions, exemplified by antibodies which bind dextran 
(Schilling et al., 1980), in which IgM antibodies have mutations. In these cases, it is 
possible that antigenic encounter may induce hypermutation but not class 
switching. Alternatively, preimmune lymphocytes may undergo hypermutation. 
Given that the above interpretation of somatic hypermutation is correct, the 
purpose of this appendix is to discuss its function. One view is that somatic 
hypermutation functions to generate antibody diversity. It is clear that many 
different types of antibodies are formed from germline sequences by this process. 
However, there are some observations which suggest that somatic mutation may do 
more than simply generate antibody diversity. First, other mechanisms for 
generating antibody diversity - i.e., multiple genes, combinatorial joining, 
junctional diversity, and combinatorial association- can potentially generate up to 
10 10 to 1013 different antibodies. At any one time, there are only 106 to 108 
different clones of B cells in a mouse (Sigal and Klinman, 1979; Eichman, 1979). 
Therefore, a mouse can only express a subset of its potential antibodies. Even over 
its entire lifetime, the entire potential repertoire of immunoglobulins may not be 
expressed. In other words, additional mechanisms to generate antibody diversity 
may not be efficacious since the increased potential for diversity may not be 
expressed by an individual. 
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Second, it appears that somatic hypermutation primarily functions late in B 
cell ontogeny. Mechanisms which generate antibody diversity usually operate early 
in B cell ontogeny. This discrepancy suggests that somatic hypermutation may have 
additional functions which cause it to be developmentally regulated in this different 
fashion. 
Third, the number of different antibodies due to hypermutation is 
inconsequential in comparison to those due to other means. For example, a mouse 
might have on the order of 108 different antibodies. Following antigenic challenge, 
on the order of dozens or hundreds of different antibody sequences may appear. 
When compared to the vast number already present, this number is insignificant. 
This conclusion is substantiated even when all stimulated B lymphocytes, responding 
to different antigens, are considered. Although there are some exceptions, 
mutation usually occurs in genes that have undergone class switch rearrangement. 
Since most B lymphocytes are of the IgM class and have not undergone class 
switching, most immunoglobulin genes would be expected to be unmutated. 
Another view is that, through hypermutation, antigen contact induces the 
cell to alter the binding specificity of its immunoglobulin. Hypermutation most 
likely operates randomly so that immunoglobulins with decreased as well as 
increased affinities are produced. Those immunoglobulins with increased antigenic 
affinity can be selected immunologically. 
As discussed below, this increase in affinity is likely to be immunologically 
significant. Hypermutation appears to act only on immunoglobulin V genes and only 
in mature B lymphocytes. Such a high level of regulation suggests that it must have 
an important function. Also, hypermutation is involved in many immune responses; 
variable region genes which undergo hypermutation include the lambda V region, 
the phosphorylcholine binding kappa V region, and the dextran, NPb, arsonate, and 
phosphorylcholine binding heavy V regions (Brack et al., 1978; Bernard et al., 1978; 
26 
Selsing and Storb, 1981; Gershenfeld et al., 1982; Bothwell et al., 1981; Crews et 
al., 1980). The frequent involvement of hypermutation in the immune response 
indicates that it may have a fundamental role in producing immunoglobulins with 
antigenic specificity. Finally, one effect of hypermutation is probably detrimental, 
since random changes in immunoglobulin sequence may inactivate some B 
lymphocytes responding to antigen. It seems likely that the beneficial effect of 
hypermutation, to produce immunoglobulins with increased binding affinity, 
outweighs this detrimental effect. Otherwise, hypermutation would be selectively 
lost in phylogeny. 
A corrollary to the conclusion that hypermutation plays an important role in 
the immune response is that without it, the immune repertoire may be too small. In 
other words, clonal expansion of exact replicas of preexisting B cells may not result 
in an effective immune response. The instructionist theories may have been 
correct to the extent that they postulated that new immunoglobulins must be made 
in response to antigen. These theories were probably incorrect in postulating how 
this might occur, namely with conformable receptors. However, in my opinion, this 
is inconsequential compared to the major issue which is whether enough different 
receptors can be expressed so that all potential antigens can be bound with 
sufficient affinity to elicit an immune response. Regarding this point, the 
instructionist theories may have been insightful. 
The hypothesis that hypermutation functions partly to alter binding 
specificity in response to antigen makes several predictions. First, the rate of 
mutation should increase in those B cells which have been stimulated by antigen. 
Even though the frequency of mutation is much higher for B cells late, rather than 
early, in ontogeny, the rate of mutation is not known. One possibility is that the 
mutation rate is constant but that mutations accumulate over time. For 
phosphoryl-choline binding immunoglobulins, one out of 40 antibodies of the IgM 
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class and 15 out of 20 antibodies of the IgG class have mutated sequences 
(Perlmutter et al., 1984). In the absence of immunological selection, IgG+ cells 
would have to be at least 100 times older than IgM+ cells in order to have 
accumulated so many more mutations. Assuming that IgM+ cells average l week in 
age (a minimal estimate), it would take longer than the lifetime of the mouse for 
IgG+ cells to accumulate mutations so frequently. Thus, the notion that the 
increase in mutational frequency simply reflects differences in cellular age is 
probably untenable. 
Rather than increased mutational rate, it is possible that immunologic 
selection is the cause of increased mutational frequency. Immunologic selection 
could cause those B cells with appropriately mutated immunoglobulin genes to 
proliferate. In this case, although the mutation rate of immunoglobulin genes would 
still be abnormally high, it would be constant throughout the immune response. 
A second prediction is that the baseline repertoire is insufficient to reliably 
mount an effective immune response. In mice, it appears that the size of the 
baseline repertoire is limited by the number of B lymphocytes. Perhaps in a larger 
animal, the increased number of B cells would be reflected in an increased 
repertoire size. If the repertoire were sufficiently large, those immunoglobulins 
that are produced as a result of somatic hypermutation in mice might be already 
present in the preimmune animal. Thus, in a larger animal, somatic hypermutation 
may play a smaller role. 
It is interesting to compare Darwin's theory of evolution, "survival of the 
fittest", with B cell development, "survival of the fittingest". Evolution results in 
the appearance of many more organisms which can overcome environmental 
selective pressures. An immune response results in the appearance of many more B 
cells which can respond to antigenic challenge. Some of these antigen-reactive B 
cells may be the result of hypermutation, i.e., targeted mutagenesis in response to 
28 
antigenic challenge. It is interesting to raise the question as to whether evolution 
might not also use a similar mechanism. There may be genes which are of central 
phylogenetic importance in the sense that they are frequently selected for 
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ABSTRACT Expression of IgA by plasmacytomas occurs as a 
result of a DNA rearrangement that brings the variable region 
gene, V 8 , a few kilobases 5' to the constant region gene, C .,. In 
this study, we show that the allelic nonexpressed C., gene also is 
rearranged in most plasmacytomas. Cloning, restriction mapping, 
heteroduplex analyses, and sequence analyses of the nonproduc-
tively rearranged C., genes from two plasmacytomas, M603 and 
Ml67, have demonstrated that the nonproductive rearrangement 
occurs within the a switching region, S.,. In each case, the same 
DNA sequence has been joined to the 5' side of C., and we have 
termed this DNA "NIRD" (for nonimmunoglobulin rearranged 
DNA). Southern blotting analyses of genomic DNAs from various 
IgG-, IgM-, or lgA-producing plasmacytomas suggest that NIRD 
is rearranged in almost all plasmacytomas. However, NIRD rear-
ranges to the S., region only in lgA-producing cells, not in IgM or 
IgG producers. Cytogenetic evidence has shown that T(l2;15) 
translocations are common in murine plasmacytomas, Immuno-
globulin heavy chain genes are located on chromosome 12, and the 
translocation breakpoint in plasmacytomas occurs near the im-
munoglobulin genes. NIRD has been mapped to chromosome 15 
by Southern blotting analysis of mouse-hamster cell lines, sug-
gesting that the non productively rearranged C" clones represent 
the T(l2;15) translocations identified cytogenetically. Therefore, 
we have identified a region of DNA on chromosome 15 that is com-
monly rearranged in transformed mouse lymphocytes. We spec-
ulate on the significance of NIRD in neoplastic transformation of 
mouse lymphocytes. 
Murine plasmacytomas (also referred to as myelomas) have been 
observed to have specific chromosomal translocations in which 
the distal portion of chromosome 15 is translocated to either 
chromosome 12 or chromosome 6 (1). The immunoglobulin 
heavy chain and K light chain gene families are located on chro-
mosomes 12 and 6, respectively, and the translocational break-
point on chromosome 12 occurs at the same region of the chro-
mosome as do the immunoglobulin genes. Trisomy of chro-
mosome 15 occurs in most murine T-cell and some B-cell leu-
kemias . Based on these observations, it has been suggested that 
a cellular oncogene located on the distal portion of chromosome 
15 may become abnormally activated, through translocation or 
triplication, and result in the neoplastic transformation of mu-
rine lymphoid cells (1). 
One explanation for the involvement of the immunoglobulin 
loci in the chromosomal translocations is that immunoglobulin 
genes undergo DNA rearrangements in B cells. These rear-
rangements may predispose the immunoglobulin genes to 
undergo chromosomal translocation. Conceivably, translocation 
The publication costs of this article were defrayed in part by page charge 
payment. This article must therefore be hereby marked "advertise-
ment" in accordance with 18 U. S. C. § 1734 solely to indicate this fact. 
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of immunoglobulin genes , which are actively transcribed in B 
cells, could increase the rate of transcription of genes residing 
near the recombinational breakpoint. There are two types of 
immunoglobulin gene rearrangements (reviewed in ref. 2). 
First, separate variable (V), diversity (D), and joining (J) gene 
segments are rearranged to create a functional V gene. These 
V-D-J or V-J joining events also are denoted V gene formations 
for the heavy and light chains, respectively. The second type 
of rearrangement, heavy chain or CH switching, occurs among 
the closely linked CH genes of which there are eight in the 
mouse (5'C"-C5-Cy3-Cy1-Cy2b-Cy20 -C,-C0 3' ). The CH genes de-
termine the class or isotype of the antibody-e.g. , Cµ makes 
IgM , ca makes IgA, etc. All CH genes except for Cs have re-
petitive elements to their 5' sides that are denoted switch (S) 
regions. For example, if the B cell is to switch from its initial 
expression of IgM to the synthesis of IgA, then the S" and S
0 
regions are joined, deleting the intervening DNA and placing 
V8 near C0 • 
Immunoglobulin gene expression in B cells exhibits allelic 
exclusion; that is , in an individual B cell, only one heavy chain 
allele and one light chain allele are expressed. The chromosome 
containing the expressed immunoglobulin gene undergoes a 
productive DNA rearrangement. Often, the chromosome car-
rying the unexpressed gene also is rearranged and these are 
denoted nonproductive rearrangements . 
In the study reported here, we analyzed the nature of non-
productive C
0 
rearrangements in murine plasmacytomas. Our 
results show that most IgA-producing plasmacytomas have a 
non productively rearranged C 
0 
on a 13-kilobase (kb) Eco RI frag-
ment. Analysis of nonproductively rearranged C0 s from two 
plasmacytomas , Y!603 and Y!l67, demonstrated that the non-
productive rearrangements occurred within the S0 region in 
both cases and that the same 5' sequence had been joined to 
C0 • We have denoted this sequence "nonimmunoglobulin rear-
ranging DNA" or NIRO. Southern blotting analyses indicated 
that, whereas most IgA-expressing tumors have a NIRD-S 0 
rearrangement, IgG- or IgY!-expressing tumors have different 
NIRO rearrangements. Thus, in IgA-producing plasmacyto-
mas, both S0 regions are rearranged whereas in IgG-producing 
plasmacytomas, neither S
0 
region is rearranged. 
Y!ost significantly, we also have demonstrated that the NIRO 
sequence is located on mouse chromosome 15. Because the C0 
gene originates from chromosome 12, these results demonstrate 
that the nonproductively rearranged ca clones from Y!603 and 
Ml67 represent the junction of a translocation involving chro-
Abbreviations: V, variable; D, diversity; J, joining; S, switch; kb, kilo-
base(s); NIRO, nonimmunoglobulin rearranging DNA; bp, base pair(s). 
~ Present address: Laboratory of Immunology, National Institutes of 
Health , Bethesda, MD 20205. 
Immunology: Calame et al. 
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mosome 15 and chromosome 12. Furthermore, the results of 
the Southern blotting analyses mentioned above define a small 
region on chromosome 15 that is almost always rearranged in 
murine plasmacytomas. 
METHODS 
Construction and Isolation of the CHM603a30 and 
CHM167a7 Clones. CH'.vl603a30 was isolated from an EcoRI 
partial library of plasmacytoma \11603 DNA in Charon 4A by 
screening with a CQ cDNA probe (3). CHM167a7 was isolated 
using a 5' Ca genomic clone probe to screen a Haelll/Alu I-
digested EcoRI linker library of plasmacytoma \11167 DNA in 
Charon 4A (4). 
DNA Blots. Ten micrograms of total genomic DNA was di-
gested to completion with restriction endonuclease, size-sep-
arated on a 1 % (wt/vol) agarose gel, and transferred to nitro-
cellulose filters (5). Filters were prehybridized, hybridized, and 
washed by using the conditions of Wahl et al. (6). Washed fil-
ters were exposed to preflashed Kodak XAR-5 film at - 70°C 
with a Dupont Cronex Lightning Plus intensifying screen for 
1-3 days. 
Somatic Cell Hybrids. Somatic cell hybrids between Chinese 
hamster and mouse spleen cells (BALB/ c) were generated and 
maintained as described (7). The mouse chromosome content 
of the hybrid clones was determined enzymatically and cyto-
genetically. Each hybrid clone was analyzed for the expression 
of25 enzymes representing linkage group assigned to 16 of the 
19 autosomes and the X chromosome as described (8, 9). En-
zymatic, cytogenetic, and Southern blotting analyses were car-
ried out on parallel cultures of each hybrid clone. 
Preparation of NIRD Probe. The 440-base-pair (bp) Msp I 
fragment from a30 (see Fig. 2) was gel purified and subcloned 
into the Cla I site of pBR322. 
Other Analyses. Heteroduplex analysis was carried out as 
described by Davis et al. (10). DNA sequence analysis was per-
formed by the partial cleavage method of Maxam and Gilbert 
(11). 
RESULTS 
Most IgA-Producing Plasmacytomas Have Similar Nonpro-
ductive C,. Gene Rearrangements. In preliminary experi-
ments , we analyzed genomic Southern blots of DNA from eight 
independently arising IgA-producing plasmacytomas with a 5' 
CQ probe (unpublished data). As expected, sperm DNA di-
gested with EcoRI revealed a germ-line 5' Ca band at 9.5 kilo-
bases (kb) whereas the different plasmacytomas gave variable-
size fragments which corresponded to the productively rear-
ranged CQ gene. Unexpectedly, however, a 13-kb EcoRI frag-
ment was present in seven plasmacytomas (H8, M511 , \11167, 
M603, S63, T15, and Y5236) but was absent from one (W3207). 
This finding suggested that similar or possibly identical non-
productive CQ gene rearrangements occurred repeatedly and 
prompted us to clone and analyze examples of such nonpro-
ductively rearranged CQ genes. 
The construction and screening of genomic libraries from the 
DNA of the plasmacytomas M603 and Ml67 have been de-
scribed elsewhere (3, 4) . Clones representative of the 13-kb 
EcoRI fragment from M603 (CHM603a30) and Ml67 
(CHM167a7) are shown in Fig. 1. 
Nonproductive C,. Clones a7 and a30 Are Identical by Het-
eroduplex Analysis. Heteroduplex analyses of the M603 non-
productively rearranged ca clone a30 with the germ-line ca 
clone a29 indicated that the two clones are homologous 
throughout the CQ gene region and for about 2.6 kb 5' to the 
CQ gene (Fig. 1). Thus, there has been a rearrangement 2.6 kb 
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FIG. l. Comparison of CHM603a30 to other Ca clones by hetero-
duplex analysis. Homology between a30 and CHSpa29 (a germ-line 
Ca clone), CHM603a6 (containing the expressed Ca gene from plas-
macytoma M603), and CHM167 a7 is shown by solid bars (sizes shown 
in kb). Natural EcoRI sites are indicated by arrows; linker EcoRI sites 
are indicated by triangles. CHM167a7 contains 3.6 kb of additional 
DNA 3' to the Ca gene which is not shown in the figure because our 
blotting studies indicate that it is a cloning artifact and it does not 
occur 3' to the C
0 
gene in the M167 genome (data not shown). Scale 
marker = 1 kb. 
5' to the CQ gene in a30 and the rearrangement occurs within 
the SQ region. Heteroduplex analyses comparing the a30 clone 
to the productively rearranged M603 Ca clone a6 (3) revealed 
that the 5' half of a30 is not homologous to the 5' portion of a6 
and thus demonstrate that in a30 the sequences upstream from 
the S" sequences are neither] H sequences nor M603 V H se-
quences. However, when the two nonproductively rearranged 
CQ clones, a30 and a7, were compared to one another by het-
eroduplex analysis , homology was observed not only throughout 
the ca genes but also in their 5' flanking sequences for at least 
7.5 kb. These results therefore demonstrate that the nonpro-
ductively rearranged CQ genes in the M603 and Ml67 plas-
macytomas have identical or similar DNA sequences joined to 
the CQ gene. This sequence, of unknown origin, is denoted 
NIRD. 
NIRD Sequences Are Joined to the S,. Region. In order to 
characterize the sites at which NIRD sequences and the germ-
line CQ flanking sequences were joined, we determined the 
DNA sequences at the boundaries between these two DNAs. 
Fine structure restriction mapping of the two clones in a 1. 5-kb 
region surrounding the S sites (Fig. 2) confirmed the homology 
observed by heteroduplexing and led to the sequence-deter-
mination strategies shown. The sequences illustrated in Fig. 3 
demonstrate that the Sa recombination point in the two clones 
differs by 94 bp. In addition, clone a7 contains approximately 
70 bp more NIRD sequences than does clone a30. Thus, al-
though clones a7 and a30 are homologous by heteroduplex 
analyses, they join NIRD and germ-line CQ flanking sequences 
at slightly different points. 
Because clones a7 and a30 both have recombinational break-
points within the SQ region, it is likely that the rearrangement 
was due to a nonproductive CH switching event. Indeed, the 
SQ recombination breakpoint from a30 lies only 2 bp away from 
the Sa site used in generating the expressed a gene in the plas-
macytoma Tl5 (12). 
Most IgA-Producing Plasmacytomas Have Nonproductive 
a Genes That Contain NIRD. The identity of the NIRD se-
quence in the Ml67 and \'1603 nonproductively rearranged CQ 
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FIG. 2. Restriction map of a30 and a7 in the vicinity of the S re-
gion. The regions subjected to sequence analyses are indicated by ar-
rows. Both clones contain one additional Msp I site that is not mapped. 
The solid bar indicates the 440-bp Msp I fragment used as a NIRD 
probe. The portion outside of the 1.7-kb Xba fragment in a7 was not 
mapped. R, EcoRI; X, Xba I; P, Pst I; M, Msp I; S, Sac I; B, BamHI; H, 
Hindlll. Scale markers are in kb. 
genes led us to subclone a DNA fragment from this region to 
use as a probe in the analysis of other IgA-producing plasma-
cytomas to determine whether their nonproductive ca rear-
rangements use NIRD sequences. A 440-bp Msp I restriction 
fragment was subcloned to use as a hybridization probe (Fig. 
2). This subclone is referred to as the NIRD probe. 
Fig. 4 shows the results of Southern blot analyses of genomic 
DNAs from five IgA-producing plasmacytomas. Embryo and 
liver DNAs contained NIRD on a 16-kb EcoRI fragment 
whereas the five IgA-producing plasmacytomas (Ml67, H8, 
Tl5, W3082, and Yl.5ll) contained NIRD on the 16-kb fragment 
and on an additional 13-kb EcoRI fragment. Because the DNA 
from the H8, Tl5, and M5ll tumors revealed a 13-kb EcoRI 
band when hybridized with either a NIRD or a Ca probe, we 






CD .0 ;;:; > a:> 0 E 
-' ::c 
,._ ::::E .., uJ ::::E 
• }i 
FIG. 4. Genomic blots of germ-line and plasmacytoma DNAs with 
the NIRD probe. DNAs were digested with EcoRI. 
conclude that, like Yl.603 and Yl.167, they have NIRD sequences 
5' to the nonproductively rearranged Ca gene. In the ~"5ll 
case, the juxtaposition of NIRD with Ca was further shown by 
using Southern blotting analysis of HindIII- and Xba I-digested 
DNAs (data not shown). By analogy, the above blotting results 
suggest that S63 and Y5236, which have a rearranged 13-kb 
EcoRI Ca band, and W3082, which has a rearranged 13-kb 
Eco RI NIRD band, have the NIRD /Ca rearrangement. Finally, 
comparison of the NIRD restriction sites from a7 or a30 to the 
restriction sites from nonproductive ca gene clones from the 
lgA-producing plasmacytomas Sl07 (13) or J558 (14) showed 
that these clones also have a NIRD /Sa rearrangement. Thus, 
it appears that as many as 10of11 IgA-producing plasmacytomas 
may have nonproductively rearranged Sa regions joined to 
NIRD. In other words, rearrangement of NIRD to the Sa region 
is a frequent event in nonproductive CH switching in IgA-pro-
ducing tumors . Moreover, the rearrangements in each IgA-pro-
ducing plasmacytoma appear to have occurred to nearly the 
same area within Sa and NIRD because the size of the restricted 
site fragments spanning the recombination breakpoint varied 
only slightly. 
NIRD Rearrangements Occur in Non-lgA-Producing Cell 
Lines but Are Not Closely Associated with the Allelic Coun-
terpart of the Expressed CH Gene. The status of NIRD se-

























FIG. 3. DNA sequence of germ-lines. (a29), M603 rearranged S. (a30), and M167 rearranged S. (a7) DNAs at the S sites. Nucleotide identities 
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FIG. 5. Genomic blots of non-IgA-producing plasmacytomas. Lanes: 
1-3, liver DNA; 4-10, plasmacytoma DNAs; A, probed with the NIRD 
probe; B, same filter probed with CH cDNA probes after washing for 
3hrin5 mMTris, pH 8.0/ 0.2 mMEDTA/ 0.05% sodium pyrophosphate 
at 68°C. Details: lanes 1-3, liver DNA digested with HindIII, Kpn I, 
and EcoRI, respectively, and probed with the NIRD probe; 4B, El 
(lgG2b) DNA digested with HindIII, probed with a C,2b probe; 5B and 
6B, IB7 (lgG3) DNA digested with HindIII and EcoRI, respectively, 
probed with a C,;i probe; 7B and 8B, P3K (lgGll DNA digested with 
HindIII and Eco RI, respectively, probed with a C,1 probe; 9B and lOB, 
HPCM2 (lgM) DNA digested with EcoRI and Kpn I, respectively, and 
probed with a cµ probe. 
mined . Genomic DNA from an Ig:vt-producing hybridoma 
(M2), an IgG3-producing hybridoma (187), an IgGl-producing 
plasmacytoma (P3K), and an IgG2b-producing plasmacytoma 
(El) was analyzed by Southern blotting. Fig. 5 shows the results 
of several enzyme digestions in which the same filter was hy-
bridized first with the NIRD probe, washed, and then hybrid-
ized with a cD NA probe corresponding to the isotype expressed 
by the cells from which the DNA was prepared. In all cases , 
a rearranged NIRD band was observed in addition to the germ-
line NIRD band seen in liver DNA. 
The parental cell line used in hybridoma fusions, SP2, ex-
hibits a 13.0-kb EcoRI band and a 6.6-kb HindIII band when 
hybridized to a NIRD probe (14). Both :vt2 and 187 exhibited 
the same size EcoRI and HindIII bands as SP2 when hybridized 
to a NIRD probe (Fig. 5; unpublished data). This similarity sug-
a:: 
w - "' ...... "" ~ w N ~ "' - ,_ Vl ...... Vl ::;) Vl Vl Vl Vl Vl Vl Vl ::c: 0 00 00 00 00 00 00 00 Vl <.( ::c: 00 w w w w w w w w :I: 
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Ge FIG . . 6. Genomic blot of somatic hamster-mouse cell hybrid DNAs. 
nom1c DNA from mouse liver, hamster, and hamster-mouse so-
kbatic cell hybrids was digested with HindIII and hybridized to a 1.2-
l HzndIII NIRD pro?e subclon.ed into pBR322 from a30. Arrowhead, 
.2-kb HmdIII band m mouse hver DNA. 
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Table 1. Se t' f grega ion o NIRO in mouse-hamster hybrids 
Chromosome Marker enzyme Concordant 
1 PEP-3 
Discordant 
2 AK-1 / SODH/ ACP-2 
3 5 
3 5 3 
* 5 4 PGD/PGM-2 3 
5 PEP-7 /PGM-1 
3 5 
6 TPI 2 6 




4 4 9 ME/ MPI 4 4 10 PEP-2/ HK-1 4 4 
11 GLK 1 7 
12 ACP-1 6 2 
13 * 6 2 
14 ES-10 1 7 
15 8 0 
16 SOD-1 4 4 
17 GLO 6 2 
18 PEP-1 2 6 
19 GOT 5 3 
x HPRT 7 
The marker enzymes, their chromosomal assignments, and the pro-
cedures used to separate the Chinese hamster and mouse enzymes have 
been described (8, 9). Marker enzyme analysis and karyotype analysis 
agreed for each chromosome. Enzyme, karyotype, and Southern blot-
ting analyses were performed on the same passage for each hybrid cell 
line. 
*Chromosomes 3, 13, and 15 have no enzyme markers; their concor-
dance/discordance was based on karyotype analysis alone. 
gests that the rearranged NIRD bands in hybridomas M2 and 
187 were donated by the parental cell line, SP2. 
In no case, however, was the rearranged NIRD band found 
on the same size restriction fragment as the relevant CH gene. 
We also have found that NIRD is not rearranged to the Ca gene 
in these cells because the Ca gene and Sa region remain in germ-
line configmation (data not shown). These results show that 
NIRD is rearranged in almost all plasmacytomas and hybrido-
mas analyzed in our study regardless of which isotype is ex-
pressed (Ig:vt, IgG, or IgA). Although in IgA-producing cells 
NIRD rearranges to the Sa region, in IgG- or IgM-producing 
cells NIRD rearranges neither to Sa nor to the S region used 
for rearrangement on the expressing chromosome. 
NIRD Originates from Chromosome 15 as Shown by So-
matic Cell Hybrid Mapping. Chinese hamster-mouse somatic 
cell hvbrids that selectivelv lose mouse chromosomes can be 
used to map mouse sequen~es to individual chromosomes. Dif-
ferent hamster-mouse hvbrid cell lines contain different arravs 
of mouse chromosomes .as determined by enzyme and kary~­
type analysis. DNA was prepared from these hybrid cells and 
analyzed by Southern blots for the presence of NIRD se-
quences. NIRD sequences mapped concordantly with mouse 
chromosome 15 but discordantly with all other mouse chro-
mosomes (Fig. 6; Table 1). Since the Ca genes originate from 
chromosome 12 and the NIRD sequences originate from chro-
mosome 15, the a30 and a7 clones , from the plasmacytomas 
M603 and :vtl67, span a translocation involving chromosome 
15 and chromosome 12. 
DISCUSSION 
This paper describes clones isolated from two IgA-producing 
murine plasmacytomas in which the same DNA sequence is 
joined to the 5' side of the ca gene by a nonproductive ca switch 
rearrangement. This sequence, termed NIRD , has been 
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rnapped to chromosome 15, thus showing that these two clones 
epresent the junction of a translocation involving chromo-
~omes 12 and 15. Nonproductively rearranged Ca genes from 
the plasmacytoma tumors Sl07 (13) and J558 (14) have been 
cloned and , by restriction site similarity, these clones also con-
tain a NIRD/Sa rearrangement. Furthermore, by Southern 
blot analysis presented here and elsewhere (13, 14), NIRD se-
quences are rearranged in 40 of 48 plasmacytomas. Previous 
cytogenetic evidence has shown that the distal portion of chro-
rnosome 15 is frequently translocated to either chromosome 12 
or chromosome 6 in murine plasmacytomas (15, 16). The sim-
plest explanation of these observations is that the a30 and a7 
clones represent the T(l2;15) translocations and that, in murine 
plasmacytomas , the NIRD sequence on chromosome 15 is fre-
quently translocated, along with the distal portion of the chro-
rnosome, to the heavy chain immunoglobulin locus on chro-
rnosome 12 or to the K chain immunoglobulin locus on chromo-
some 6. 
Several lines of evidence suggest that NIRD rearrangement 
is limited to plasmacytomas . First, thymus, liver, and embryo 
DNAs show only the germ-line NIRD band (Fig. 4; unpub-
lished data). Second, NIRD rearrangement is not observed in 
EcoRI-digested DNAs from a helper I-cell line (HT-1), a cy-
totoxic I-cell line (CTLL16), or two suppressor I-cell hybrid-
omas (B3B5 and C4#4) (unpublished data). Third, except for 
the NIRD rearrangement donated by the parental cell line , 
SP2, NIRD rearrangement was not observed in 10 hybridomas , 
suggesting that NIRD is not rearranged in normal B lympho-
cytes (Fig. 5; ref. 14). Thus , these results suggest that NIRD 
rearrangement is specific for plasmacytomas. 
One plausible explanation for NIRD rearrangement in plas-
macytomas is that NIRD may contain an oncogene residing on 
chromosome 15 which can be activated bv translocation to chro-
mosome 12. For example, when B cells ~ndergo CH switching, 
DNA rearrangement of S regions may predispose the immu-
noglobulin heavy chain genes to translocation . In those cases 
in which an S region joins to NIRD, the NIRD oncogene may 
become activated, contributing to neoplastic transformation. A 
precedent for this hypothesis can be found in avian leukosis 
virus-transformed cells (17). In this case, a cellular oncogene, 
c-myc, is expressed at a higher level when it is activated by the 
insertion of a retrovirus , avian leukosis virus. Increased expres-
sion of c-myc by retrovirus-mediated promotor insertion is be-
lieved to cause neoplastic transformation in these cells. 
Several points are worth noting regarding NIRD rearrange-
ments. First, although promotor insertion seems to be the sim-
plest explanation, it is not known how T(l2;15) translocations 
can lead to neoplastic transformation. For example, transloca-
tions could derepress the NIRD gene. Alternatively, the NIRD 
gene could be a regulatory gene whose activation or repression 
could control oncogenes residing elsewhere. Furthermore, the 
translocated immunoglobulin gene is missing its normal pro-
motor that resides with the VH gene. Thus , even if T(l2;15) 
translocations activated an oncogene residing at NIRD, the 
mechanism of activation is not clear. Perhaps the translocation 
is actually reciprocal so that a 5' V wNIRD 3' sequence resides 
in the plasmacytomas. Alternatively, the translocated Ca gene 
may activate nearby sequences via enhancer or chromatin ef-
fects (18). 
Second, because some plasmacytomas show an unrearranged 
NIRO band on Southern blots , there may be a different mech-
anism for transformation in these cells. Alternatively, rear-
rangements may occur on chromosome 15 that are undetected 
by the NIRD probe. For example, by Southern blotting anal-
ysis, MOPC315 is reported to have no NIRD rearrangement 
\14) whereas a translocation involving chromosome 15 (D3/E) 
is detected cytogenetically (15). 
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Third , because chromosome 15 is observed to translocate to 
chromosome 6 (16) (which contains the immunoglobulin K 
chains) and because light chains do not undergo CH switching, 
it is possible that translocations may be induced bv V-J or V-D-
J joining as well as by CH switching. 
Fourth , the type of NIRD rearrangement found in plasma-
cytomas seems to correlate with the expressed isotype. For ex-
ample, cloning and Southern blotting analysis suggest that 
NIRD is joined to Sa in 10of11 IgA-producing plasmacytomas. 
However, NIRD is not joined to Sa in four lg:\1- and IgG-pro-
ducing lines. 
Fifth , because trisomv of chromosome 15 is observed in mu-
rine T- and B-cell leuke~ias (3), it is possible that NIRO is in-
volved in leukemogenesis . In addition , in human Burkitt lym-
phoma, translocations involving chromosome 8 and chromosome 
2, 14, or 22 are known to occur (3). Because chromosome 2 con-
tains the K immunoglobulin genes , chromosome 14 contains the 
heavy chain genes, and chromosome 22 contains the A light 
chain genes, it is possible that an analogous situation exists in 
these tumors in which a sequence similar to NIRD resides on 
human chromosome 8. 
Finally, NIRO rearrangement in murine plasmacytomas may 
not be involved in oncogenesis at all. These rearrangements 
may have significance in a way not yet identified. 
While this manuscript was in preparation, \ilarcu and co-
workers (19) reported that a similar T(l2;15) chromosomal trans-
location event occurs in the murine plasmacytoma J558. 
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Chapter 4 
Rearrangment of switch regions in a 
Pre-B cell line 
37 
Introduction 
An immunoglobulin heavy chain is composed of a variable region, V H' which 
helps bind antigen, and a constant region, CH, which carries out effector 
functions. Each CH region may have a different effector function. For example, 
IgM appears as a pentamer and can react to low concentrations of antigen. IgG is 
effective at activating complement. IgE can stimulate mast cells and IgA can cross 
the intestinal epithelium to function within the gut. 
Antigenic challenge stimulates appropriate B cells, which originally express 
IgM, to respond in two ways. First, they proliferate and secrete IgM. This response 
is effective in clearing antigen. Second, they undergo class switching by producing 
immunoglobulins with the same VH region but with a different CH region (Cooper 
et al., 1977; Pernis, 1977). Thus, the capability to bind a particular antigen is 
retained while the effector response is modified. The type, amount and location of 
antigen may affect class switching. For example, lgA expression is observed from 
B cells in the Peyer's Patch whereas B cells expressing lgG are observed in 
peripheral lymph nodes. 
Immunoglobulin class switching involves a DNA rearrangement (fig. lA, 
Davis et al., 1979; Kataoka et al., 1980; Sakano et al., 1980). Initially, a VH gene 
segment is linked to a Cu gene segment. Class switching causes a deletion 
beginning in the Su region and ending in another S region. As a result, the Cu gene 
segment is deleted and replaced by another CH gene segment. 
In order to characterize the mechanism of class switching, the sequence of 
the switch regions and the endpoints of the rearrangements have been studied. 
Switch regions consist of many small repeats (Dunnick et al., 1980; Takahashi et al., 
1980; Kataoka et al., 1981; Davis et al., 1980; Sakano et al., 1980; Obata et al., 
1981). In the Su and Salpha regions, which have been the most extensively studied, 
some independently derived rearrangement breakpoints occur within a few 
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nucleotides of each other. Since switch regions extend for greater than one 
thousand base pairs, the close proximity of these breakpoints may be significant, 
suggesting that there may be hotspots for rearrangement within the switch regions. 
Interpretation of these results has been difficult. The presence of repeats in 
switch regions has been interpreted to signify that class switching occurs by 
homologous recombination (Honjo et al., 1981 ). Alternatively, these repeats may 
mean that sequences which are recognized by specific class switching enzymes are 
reiterated to improve the efficiency of the rearrangement (Davis et al., 1980; 
Sakano et al,. 1980; Piccoli et al., 1984; Marcu et al., 1982). Various sequences 
have been found at or near rearrangement breakpoints and have been proposed to 
mediate the rearrangements (Davis et al., 1980; Sakano et al., 1980; Honjo et al., 
1981; Marcu et al., 1982). 
The short recognition sequences proposed by Marcu et al. (1982) and Honjo et 
al. (1980) are both heavily repeated within S regions. A section of all S regions 
consists of long stretches in which these simple sequences are tandemly repeated 
whereas other sections display an interspersed pattern of repeats. These repeats 
are reiterated to such an extent that it is not surprising that rearrangement 
breakpoints should, by chance, fall near one of them suggesting that their 
ubiquitous proximity to switch sites is not significant. Furthermore, the following 
two observations suggest that these sequences may not mediate rearrangement. 
First, the rearrangement breakpoints in the Su, Sgamma2b and Salpha regions do 
not occur in those sections which contain the highest concentrations of the putative 
recognition sequences (Davis et al., 1980; Sakano et al., 1980; Kataoka et al., 
1980). Second, in the Su and Salpha regions, the rearrangement breakpoints tend to 
cluster whereas the putative recognition sequences are dispersed. This observation 
is not consistent with the idea that all of the repeats are functionally capable of 
mediating class switching. 
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Class switching has been studied in the preB cell line 1881 (Siden et al., 
1979). This cell line was established by transforming murine bone marrow cells 
with Abelson murine leukemia virus and was found to have the following 
properties. Immunoglobulin expression can be stimulated by a mitogen, LPS (Rice 
and Baltimore, 1983). Rearrangement of kappa light chain genes occurs 
spontaneously in vitro (Riley et al., 1981). Point mutations occur at a much higher 
frequency in the V H gene segment than in non-immunoglobulin genes suggesting 
that the VH genes are being modified by somatic hypermutation (Wabl et al., 1984; 
M. Wabl, pers. comm.). Finally, 1881 can switch expression from Cu to 
CgammaZb' Up to 30% of a population can express IgG 2b and this heterogeneity 
can be maintained upon cloning. Southern blot analysis of cells expressing 
CgammaZb has revealed that a class switch rearrangement has occurred (Burrows 
et al., 1983 ). 
We have attempted to help clarify the mechanism of class switching by 
taking advantage of the switching activity in 188 l. In this report, Su and 
SgammaZb regions were introduced into the 188 L cell line by DNA mediated gene 
transfer using a selectable marker, SY2GPT (Mulligan and Berg, 1981). The switch 
regions were placed on either side of the EcoGPT gene so that class switch 
rearrangement would delete the EcoGPT gene. When GPT- revertants from GPT+ 
transformants were selected, it was found, in four out of four cases, that the 
EcoGPT gene had been deleted but that the deletion endpoints were not in switch 
region DNA. Since class swtich rearrangements would be expected to result in 





In an attempt to further analyze the mechanism of immunoglobulin class 
switching, Su and Sgamma2b region DNAs were introduced into the preB cell line 
1881, which continually switches from IgM to IgG 2b expression in vitro. If the 
endogenous switching activity in 1881 can recognize the newly introduced switch 
region sequences, then these sequences should recombine and thereby delete the 
region between them. As a result, the selectable marker EcoGPT, which was 
inserted between the switch regions, would be lost. Thus, loss of EcoGPT 
expression might indicate that the newly introduced switch regions had undergone 
class switch rearrangement. 
The EcoGPT gene encodes xanthine guanine phospho-ribosyl transferase 
(XGPRT) and confers a GPT+ phenotype (Mulligan and Berg, 1981). It can be used 
as a selectable marker in mammalian cells and it is possible to select cells which 
either possess or lack EcoGPT gene activity. This bacterial enzyme is used in the 
purine salvage pathway. In the absence of de nova purine biosynthesis, cellular 
survival depends on the salvage of hypoxanthine, xanthine or guanine from the 
medium. The bacterial enzyme XGPRT can utilize xanthine whereas the 
endogenous mammalian enzyme HGPR T cannot. Therefore, if xanthine is the only 
purine present in the medium, mammalian cells with EcoGPT activity can be 
selected by blocking de nova purine biosynthesis with mycophenolic acid (MPA). 
Conversely, since GPT+ cells are sensitive to 6-thioxanthine or 8-azaxanthine, the 
lack of EcoGPT gene activity can be selected using these xanthine analogs (J. F. 
Nicholas, pers. comm.). Before class switching, transformed 1881 cells should be 
GPT+ and can be selected in medium containing MPA and xanthine; after class 
switching, the cells should be GPr and can be selected in medium containing 6-
thioxanthine (fig. lA). 
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The immunoglobulin class switching vector, pugamma9, is shown in figure 
lB. Some of its components are described below. First, the vector contains the Su 
region on a 3.8 kb Xba I fragment. This fragment contains all known Su sites. 
Second, an 0.8 kb Xba I to Eco RI fragment that contains most of the Sgamma2b 
region was included. Only the switch site from the plasmacytoma MOPC4 l, which 
occurs outside of this fragment toward the 3' side, is missing (Sakano et al., l 980; 
Takahashi et al., 1980). 
Third, the immunoglobulin enhancer sequence was inserted downstream of 
the EcoGPT gene since it is required for EcoGPT expression in B cells (Gillies et 
al., l 983; Queen and Baltimore, l 983; Banerji et al., l 980). Omission of the 
immunoglobulin enhancer from this vector reduced the frequency of GPT+ 
transformants one hundred to one thousand fold (see below). 
Fourth, the gamma2b repeat sequence was used as a control for homologous 
recombination. The gamma2b repeat region has many repeats which are also 
present, although to a lesser extent, in the Sgamma2b region. Deletion of the 
EcoGPT gene via homologous recombination should have an upstream breakpoint in 
the gamma2b repeat, which is homologous to the Sgamma2b region, rather than in 
the Su region, which is less homologous. Therefore, switch rearrangements may be 
distinguished from homologous recombination since the former should have 
breakpoints in the Su region whereas the latter should have endpoints in the 
gamma2b repeat region. 
Fifth, the shuttle vector, pSVOD, allows the switch vector, integrated in the 
B cell genome, to be rapidly reisolated in E. coli. The vector includes pBR322-
derived sequences as well as the SV40 origin of replication. The SV40 large T 
antigen can cause overreplication of SV40 sequences which are integrated in the 
chromosome. As a result, the SV40 sequences appear as extrachromosomal DNA 
(Botchan et al., l 979). Cos cells constitutively express SV40 large T antigen 
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(Gluzman, 1981). When these cells are fused to cells carrying an integrated copy of 
SV40, the integrated copy overreplicates and appears extrachromosomally (Botchan 
et al., 1980). Similarly, fusion of Cos cells with 1881 cells which have been 
transformed with pugamma9 should cause the switch vector to appear 
extrachromosomally. Extrachromosomal DNA can be easily separated from 
genomic DNA by a Hirt extraction (Hirt, 1967) and the purified DNA can be used to 
transform E. coli. 
Transformation of 1881.l with pugamma9 
An HGPR T- mutant of 1881, 1881.1, was selected using 6-thioguanine. This 
cell line was transfected with 5 µg of pugamma9, 5 µg of B6beta2u (see below) and 
90 µg of genomic 1881.1 carrier DNA as a calcium phosphate precipitate (Oi et al., 
1983; Rice and Baltimore, 1983). Cells were plated in microtiter wells and GPT+ 
cells were selected. Transforman ts appeared after two to three weeks at a 
frequency of 5 x 10-6 clones/ µg vector /cell. Four clones were arbitrarily chosen for 
further analysis: F 1, J 1, I l and 12. 
The B6beta2u DNA contains the genomic beta2 microglobulin gene from the 
C57BL/6 mouse strain (Parnes and Seidman, 1982) and was included in the 
transformation as a second marker. Beta2 microglobulin produced by C57BL/6 and 
Balb/c mice can be distinguished by monoclonal antibodies. Since 1881.1 is of 
Balb/c origin, expression of the C57BL/6 beta2 microglobulin gene could be 
observed in the transformants. Rearrangements induced by class switching should 
not alter expression of this second marker. However, random deletion of EcoG PT 
may include the second marker as well. Thus, the C57BL/6 beta2 microglobulin 
gene was employed to distinguish class switch events from random deletions. 
Unfortuneately, none of the transformants expressed the C57BL/6 beta2 
microglobulin gene as evidenced using monoclonal antibodies in a radioimmune 
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assay (data not shown). As discussed below, it is likely that co-transformation of 
1881 cells is inefficient and accordingly, cells selected for GPT expression rarely 
have B6beta2u expression. 
Southern blotting experiments were performed to prove that the GPT+ 
transformants contained copies of the pugamma9 switch vector. Genomic DNA 
from 1881.1 and the four transformants was cut with Eco RI and analyzed using 
pSV2GPT DNA as a probe (fig. 2A). No pSV2GPT sequences were present in 1881.1 
DNA whereas F 1, J 1, I I and 12 DNAs all exhibited one or more bands. Thus, these 
cell lines contain copies of the switch vector. 
Next, pSgamma2b was used as a probe in an experiment similar to the one 
described above in order to determine the approximate copy number of the vector 
in the transformants (fig. 2B). The lane with 1881.1 DNA shows bands at 14, 12 and 
8.5 kb, which are probably due to rearrangement of the endogenous Sgamma2b 
region, as well as the germline Sgamma2b and Sgamma2a bands at 6.7 kb. Lanes 
with DNA from the four transformants all show one or more bands in addition to 
the bands seen in 1881.1 DNA. The extra bands at 3.5 kb and at 0.8 kb are probably 
due to the presence of the switch vector since pugamma9 has plasmid and 
Sgamma2b sequences on these sized fragments. These bands are similar in intensity 
to the bands at 6.7 kb, due to the endogenous Sgamma2b and Sgamma2a regions. 
Therefore, only one or a few copies of the switch vector are likely to have 
integrated in the transformants. 
Analysis of the transformants 
Different cell clones may have different class switching activities (Burrows 
et al., 1982) and the particular conformation of pugamma9 in each transformant 
may affect its ability to rearrange. Accordingly, the transformants may rearrange 
the switch vector at different rates. First, the number of cells positive for IgG was 
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measured in all four transformants and revealed that all had between 20% - 40% 
IgG+ cells. This observation suggests that all four transformants retained 
approximately equal levels of class switching activity. Next, the frequency of 
reversion from GPT+ to GPT- was measured to see which transformants might 
rearrange pugamma9 frequently. Since these cells are HGPRT-, cells which are 
also XGPRT- should be resistant to 6-thioguanine. The transformants were grown 
in non-selective medium for seven days and then plated at various dilutions into 
microtiter wells in medium containing 6-thioguanine. Colonies appeared after 
seven days and were grown as revertant clones. The reversion frequencies varied 
from approximately 10-3 to 10-5 (table 1). The cell line Jl had a high reversion 
frequency, 1.1x10-3, and was therefore analyzed further. 
The genomic arrangement of the switch vector in J l was studied by 
reisolating integrated copies as molecular clones. A library was constructed in the 
lambda insertion vector embl 3 with DNA partially digested with the restriction 
enzyme Sau 3A. If the insert in the lambda vector contains the pBR322 origin of 
replication and beta-lactamase gene, then it can replicate in E. coli lysogenic for 
lambda and confer ampicillin resistance. Accordingly, clones containing functional 
pSVOD sequences were isolated as phasmids by infecting a lambda lysogen, SS13, 
and selecting with ampicillin. Those clones that also contained SV2GPT sequences 
were identified by hybridization to an SV2GPT probe. Two copies of SV2GPT were 
found integrated in the genome of J l. Many clones of each copy of S V2GPT were 
isolated; lambda] 1-4 and lambda] 1-2 are representatives of each of the copies (fig. 
3). 
The copy of SV2GPT contained in lambda] 1-2 is probably not expressed. 
Restriction map analysis of lambda J 1-2 indicated that f tanking DNA derived from 
the host cell's genome joined the switch vector DNA within a 3.9 kb Hind III 
fragment which contains the EcoGPT gene. It is possible that the EcoGPT 
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transcription unit has been truncated. Even if this is not so, the breakpoint must 
certainly delete the immunoglobulin enhancer which was located downstream of the 
3.9 kb Hind III fragment and is completely missing. Since the immunoglobulin 
enhancer is required for expression, this gene is probably inactive. 
The copy of pugamma9 contained in the clone lambda] 1-4 is probably 
expressed since both the EcoGPT gene and the immunoglobulin enhancer are 
intact. In addition, the upstream Su and downstream Sgamma2b regions are 
present. Thus, this cell line is a reasonable candidate to determine whether class 
switching can rearrange newly introduced switch regions and thereby delete the 
EcoGPT gene. 
Analysis of the revertants 
Five GPT- revertant clones of J l were isolated using 6-thioguanine: J 1.2, 
J 1.5, J 1.6, J 1.7 and J 1.8. The context of the pugamma9 vector in these clones was 
analyzed by genomic blotting and molecular cloning to see if a class switch 
rearrangement had occurred. Genomic DNAs were isolated, cut with Hind III, and 
analyzed by Southern blotting using SV2GPT as a probe. As shown in figure 4A, the 
parental J l cell line contains a 3.7 kb band, containing the non-expressed EcoGPT 
gene, and a 3. 9 kb band, containing the expressed gene. All five clones have bands 
at 3.7 kb indicating that the non-expressed copy of EcoGPT has been retained. 
Three clones, Jl.5, Jl.6 and Jl.7, have deleted the band at 3.9 kb indicating that 
the expressed EcoGPT gene has been deleted. Two clones, J 1.2 and J 1.8, are 
missing the 3.9 kb band but contain an extra band at 9.5 and 11 kb, repectively. In 
these cases, it appears that a rearrangement has occurred within the 3. 9 kb Hind III 
fragment which contains the expressed EcoGPT gene. 
These revertants were further analyzed using genomic DNA that was cut 
with Eco Rl, blotted and hybridized to a pSVOD probe. The parental Jl DNA has a 
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band at 3.5 kb, which is closely linked to the expressed EcoGPT gene, and a band at 
3.3 kb, which is near the non-expressed EcoGPT gene. In all clones analyzed (J 1.2, 
J 1.5, J 1.6andJ1.7), the 3.5 kb band is deleted (fig. 4B). In clones J 1.5, J 1.6 and 
J 1.7, class switch rearrangement would be expected to have a breakpoint in the 
Sgamma2b region resulting in a deleted EcoGPT gene and an unrearranged pSVOD 
fragment. Since both sequences are deleted, the deletion probably does not have a 
breakpoint in the Sgamma2b region and therefore, is not due to class switching. In 
clones J 1.2 and J 1.8, a deletion downstream of the EcoGPT gene has removed the 
pSVOD sequences and one of the deletion endpoints occurs within or near the gene. 
Next, EcoGPT expression in the revertant clones was analyzed by Northern 
blot analysis. Poly A+ RNA was isolated, blotted and hybridized to an SV2GPT 
probe. As expected, in lanes containing J l.5, J 1.6 and J 1.7 RNA, which have 
deleted EcoGPT genes, no hybridization was observed (fig. 5). However, in lanes 
containing J 1.2 and J 1.8 RN As, hybridization was observed. In the lane containing 
RNA from J 1.2, the band was much less in intensity than in the lane containing J l 
RNA but was of the same size. In J 1.8, the intensity was similar but the RNA was 
different in size. 
The ability to restore EcoGPT activity in the revertants was tested. After 
seven days in nonselective media, 3x 106 cells from each clone were placed in 
microtiter wells in medium containing MPA and xanthine. No GPT+ cells were 
obtained from the J l.5, J 1.6 and J 1.7 clones consistent with the evidence 
suggesting the the EcoGPT gene had been deleted. The J 1.2 and J 1.8 cells produced 
GPT+ clones at an approximate frequency of 10-3 and 10-4 respectively. 
In summary, genomic Southern blotting, Northern blotting and revertant 
analyses suggest that the J l.5, J 1.6 and J 1.7 revertants have a large deletion 
including the EcoGPT gene and pSVOD sequences. In these cells, EcoGPT RNA is 
not expressed and GPT+ cells are never observed. Since the deletion probably does 
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not have a breakpoint in the Sgamma2b region, it is likely that the rearrangement is 
not due to class switching. The J 1.2 and J 1.8 clones have a deletion including the 
pSYOD sequences and ending near or within the EcoGPT gene. In J 1.2, much less 
EcoGPT RNA is expressed whereas in J 1.8, the RNA is different in size. In both 
these cell clones, it is possible to select cells in which the EcoGPT gene has been 
reactivated. It is possible that a class switch rearrangement, with one endpoint in 
the Sgamma2b reg ion and the other endpoint in downstream sequences, could have 
caused these deletions. 
In order to determine whether the deletion in J 1.8 had a breakpoint in the 
Sgamma2b region, molecular clones of the rearranged EcoGPT gene were isolated. 
Genomic DNA from J 1.8 was cut with Hind III and fragments 11 kb long were 
Cloned in the lambda vector lambdaNM762. A map of the rearranged fragment is 
shown in figure 6. When the rearranged EcoGPT gene from J 1.8 is compared to the 
unrearranged gene from J 1, it can be seen that the rearrangement has most likely 
occurred at the 3' end of the gene between the Barn HI and Eco Rl sites. The Barn 
HI site marks the end of the EcoGPT transcription unit and the Eco Rl site marks 
the beginning of the immunoglobulin enhancer. Since the rearrangement breakpoint 
is probably downstream of the EcoGPT transcription unit, it is likely that loss of 
gene activity was caused by deleting the immunoglobulin enhancer. Interestingly, 
this mutation alters the size of the EcoGPT RNA and not the amount (fig. 5). Since 
the breakpoint must be in SY40 sequences derived from SV2GPT, it appears unlikely 
that this rearrangement is due to class switching. Rather, it is more likely that 
random deletions, as in J 1.5, J 1.6 and J 1.7, have occurred. 
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Discussion 
Rearrangement of pugamma9 sequences in 1881.1 cells 
In this report, a cell line with endogenous class switching activity, 1881.1, 
was transformed with the immunoglobulin class switching vector pugamma9. 
Molecular cloning and genomic Southern blotting analyses of one transformant, J 1, 
indicated that one expressed copy of EcoGPT had been integrated and that Su and 
Sgamma2b regions were located immediately upstream and downstream of this gene 
respectively. Transformants which had reverted to GPT- were selected and two 
types of mutation were observed. In the first type, as exemplified by the J 1.5, J 1.6 
and J 1.7 revertant cell lines, a large deletion removed the EcoGPT gene and 
adjoining pBR322 sequences. This observation indicates that the endpoints of this 
deletion cannot be in the Sgamma2b region and therefore, this deletion is probably 
not caused by a class switch rearrangement. In the second type, seen in the J 1.2 
and Jl.8 cell lines, a deletion including the pSVOD sequences but ending within or 
near the EcoGPT gene was observed. The deletion endpoint near the EcoGPT gene 
in J 1.8 was analyzed further. Restriction map analysis of a molecular clone 
containing this deletion endpoint revealed that the breakpoint occurred in SV40 
sequences derived from the 3' end of the EcoGPT gene and not in immunoglobulin 
enhancer or switch region sequences. Again, this result implies that the deletion 
was not due to immunoglobulin class switching. 
An underlying assumption in this report is that switch regions, which contain 
the rearrangement breakpoints, also contain the sequences which mediate the 
rearrangements. It is possible that the rearrangement breakpoint may lie at a 
distance from the sequences that promote rearrangement. Precedent for such a 
recognition mechanism include endonucleolytic cleavage by type 1 restriction 
endonucleases and recombination mediated by chi sequences in lambda phage (Stahl, 
49 
1979). In both cases, recognition of a specific sequence results in a rearrangement 
oftentimes many kilobases away. If this mechanism were true for class switching, 
then the recognition sequences could be separate from the rearrangement 
breakpoints. The switch regions in pugamma9 might not contain the sequences 
necessary to promote class switching. Even if it did contain these sequences, class 
switching could not be distinguished from random deletion since both 
rearrangements could have breakpoints in flanking DNA. 
In this experiment, a second marker, the C57Bl/6 beta2 microglobulin gene, 
was cotransfected with pugamma9 in an effort to distinguish random deletions from 
specific class switch rearrangements. If the beta2 microglobulin gene integrated 
near pugamma9, then it should be deleted by large deletions but not by class switch 
rearrangements. This approach failed for two reasons. First, none of the four 
transformants expressed the beta2 microglobulin gene. In a similar experiment, the 
TK gene was cotransfected with pugamma9 and, as before, GPT+ cells did not 
express the second marker. Specifically, a TK- derivative of 1881.1, Al (Burrows 
et al., 1983), was transformed with 5 µg pugamma9, 5 µg pTK and 90 µg carrier 
DNA. Out of fifty GPT+ clones tested, none were TK+. The lack of TK+ 
transformants was not due to a failure of the TK promoter to be expressed in B 
cells. Essentially the same results were obtained when a recombinant gene was 
used in which TK coding sequences were expressed from a metallothionein 
promoter. It is unknown why the beta2 microglobulin, the pTK and the pmetTK 
genes are not expressed in the GPT+ transformants. Perhaps cotransfer of unlinked 
genes in B cell transformation is inefficient or only a small fraction of integrated 
genes are expressed. 
Second, even if a second marker were to be cotransfected with pugamma9, 
many random deletions could not be distinguished from class switch 
rearrangement. In order to distinguish these two types of rearrangement, most 
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random deletions would have to be large so that the second marker would usually be 
lost. There are many cases in this experiment which show that this is not so. For 
example, two out of five random deletions had breakpoints near or within the 
EcoGPT gene. Most likely, these deletions are small rather than large since 
deletion endpoints are easily found. Also, in these two cases, if the second marker 
were to be located upstream of the EcoGPT gene, it would not have been affected 
by the rearrangement. In the transformant J 1, a non-functional copy of pugamma9 
was integrated and this copy was absent in only one of the five revertant clones of 
Jl. This result shows that other sequences which are integrated along with the 
expressed copy of pugamma9 are not usually absent when pugamma9 is removed by 
deletion. In summary, these results suggest that random deletions which remove 
the EcoGPT gene may be small and will not dependably remove a second, linked 
marker. 
Future studies based on the preliminary work presented here may benefit 
from analyzing other transformants or by isolating cells which have recently 
undergone class switching. Only one transformant, J 1, was studied in detail; other 
transformed clones may rearrange the pugamma9 vector by class switching. The 
EcoGPT reversion frequency for clone I2 is high (l x 10-3) and would thus be a good 
candidate for further analysis. 
The high frequency of IgG+ cells in a population of 1881 cells may possibly 
be the result of a high rate of class switching. Alternatively, this frequency may be 
due to selective proliferation of IgG+ cells or to their gradual accumulation in the 
population over time. Thus, it may not be valid to assume that the 1881 cell line 
has a high rate of IgM to IgG 2b class switching only because many of its cells 
express IgG2b. Even if the rate of class switching in 1881 cells is low, it should be 
possible to select cells which have recently switched from IgM to IgG expression. 
From a population of cells which initially expressed IgM exclusively, IgG+ cells 
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could be selected. In these cells, it is possible that the pugamma9 vector might 
rearrange more readily. 
Experimental techniques 
Some of the techniques employed in this report are novel and merit 
discussion. The immunoglobulin enhancer region was needed for expression of the 
EcoGPT gene in the preB cell 1881. The vector pugamma8 differs from pugamma9 
in that it lacks the immunoglobulin enhancer. Using 5 µg pugamma9 and 95 ug 
carrier DNA, a transformation efficiency of 5xl0-6 clones/µg pugamma9/cell was 
routinely observed. Under analagous conditions, pugamma8 transformed 1881.1 at a 
frequency of less than 2x10-lO clones/ug pugamma8/cell. This difference in 
transformation frequency is probably due to the inability of EcoGPT to be 
expressed without an enhancer in B cells. If pugamma8 is not diluted with carrier 
DNA during transformation, a transformation frequency of approximately lxl0-9 
clones/ug pugamma8/cell is observed. Southern blot analysis of these 
transformants revealed that up to fifty copies of pugamma8 had been integrated. It 
appears that fifty SV40 promoters lacking immunoglobulin enhancers, each 
inefficiently expressed, could collectively express enough EcoGPT to pass 
selection. The reduction in transformation frequency when carrier DNA is used 
may reflect the inability of pugamma8 to integrate in high copy numbers when 
heavily diluted with carrier DNA. These results are consistent with other studies 
which suggest that an immunoglobulin enhancer is required for some promoters to 
function in B cells (Banerji et al., 1983; Queen and Baltimore, 1983; Gillies et al., 
1983). 
Further support for the need of an immunoglobulin enhancer comes from 
analysis of the J 1.8 revertant. In J 1.8, a rearrangement has probably occurred 
downstream of the EcoGPT gene thereby deleting the immunoglobulin enhancer. 
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Thus, it appears that an expressed EcoGPT gene (i.e., in J 1) became dormant when 
the immunoglobulin enhancer was deleted (i.e., in J 1.8). An important caveat to 
this conclusion is that analysis was performed only by restriction mapping. The 
integrity of the EcoGPT gene was not proven by sequence data. 
The published selection medium was modified (Mulligan and Berg, 1981). The 
concentration of MPA was decreased from 25 µg/ml to 1 µg/ml. Even at this lower 
concentration, most non-transformed B cells died within 48 hr after the addition of 
MPA. Also, hypoxanthine or adenine were added to the selection medium since it 
was found that GPT+ transformants required either of these purines for growth. 
Presumably, MPA inhibits some step in de nova purine synthesis. Typically, adenine 
rather than hypoxanthine was added because hypoxanthine can competetively 
inhibit the utilisation of xanthine by XGPRT. 
A method was developed for selecting cells which do not express the 
bacterial enzyme XGPRT but may express the mammalian enzyme HGPRT. The 
bacterial but not the mammalian enzyme is capable of utilizing xanthine and thus 
the xanthine analogs 6-thioxanthine and 8-azaxanthine. These analogs become 
toxic when XGPRT, but not HGPRT, is present and allow one to select mammalian 
cells which have lost EcoGPT expression. The ability to select for mammalian cells 
which either have or lack a marker can be useful in many cases, including the one 
presented here. 
However, caveats to the use of the selection scheme discussed above, shown 
in the evidence presented below, are that not all cells may be sensitive to xanthine 
analogs and relatively high levels of XGPRT expression may be required for 
sensitivity. In 1881.1, GPT+ cells are sensitive to 6-thioxanthine, 8-azaxanthine or 
6-thioguanine. However, twenty times more 6-thioxanthine or 8-azaxanthine 
(loo µg/ml) than 6-thioguanine (5 µg/ml) are required for cell death suggesting that 
the xanthine analogs are less toxic than the guanine analog. 
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Cells which express low amounts of XGPRT can grow in the presence of 
MPA as well as 6-thioxanthine or 8-azaxanthine. A gene consisting of the 
metallothionein promoter, intron and polyadenylation site as well as the XGPRT 
coding region was constructed. This gene, metGPT, can transform 1881.l cells at a 
frequency (2xl0-6 clones/µg pmetGPT /cell) which is only slightly lower than that of 
pugamma9 showing that the metallothionein promoter does not require the 
immunoglobulin enhancer for expression in the preB cell 1881. The pmetGPT 
transformants appear after three weeks and subsequently grow more slowly than 
pugamma9 transformants suggesting that the pmetGPT gene is expressed less 
efficiently than the EcoGPT-immunoglobulin enhancer gene. Cells that are 
transformed with pmetGPT are not sensitive to either 6-thioxanthine or 8-
azaxanthine (data not shown). It appears that a low level of expression of XGPRT, 
such as that produced by pmetGPT, allows resistance to both MPA, thus giving a 
GPT+ phenotype, as well as xanthine analogs, thus giving a "GPr" phenotype. 
Some cells are impervious to 6-thioxanthine or 8-azaxanthine regardless of 
whether they express XGPR T. L cells were transformed with pugamma8. The SV40 
promoter should transcribe efficiently in a mouse fibroblast and yet, these cells 
were resistant to 6-thioxanthine or 8-azaxanthine. 
Materials and Methods 
Cell culture 
The 1881 and Al cell lines were a gift from Dr. D. Baltimore and Dr. M. 
Wabl respectively. The 1881 cell line was carried in RPM! 1640, 10% fetal calf 
serum and 50 µM betamercaptoethanol (RBF 10 medium). For freezing, cells were 
pelleted and resuspended in freezing medium (Dulbecco's modified Eagle's meduim, 
10% calf serum, 10% dimethylsulfoxide). The cells were then sequentially placed 
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for 5 minutes at 4°C, .5 to 2 hrs at -20°C, overnight at -70°C and stored 
permanently in liquid nitrogen. 
Selection of mutants 
Cells lacking HGPR T were selected using 6-thioguanine. Cells in log phase 
growth (l-2x106 cells/ml) were pelleted and resuspended at 106 cells/well in 24 well 
microtiter dishes in medium containing 5µg/ml 6-thioguanine. Half of the medium 
was replaced every third day. After two weeks, l3 clones appeared from 5.5x 107 
cells (2.3xl0-7) and were designated 1881.l to 1881.13. The frequency of reversion 
to HGPRT+ was tested by selecting in HAT media (15 µg/ml hypoxanthine, l µg/ml 
aminopterin, 5 µg/ml thymidine). Cells were grown in neutral media for seven days 
and then plated in 24 well dishes. Clones appeared after two weeks: 1881. l 
produced 11 colonies from 108 cells (l.lxl0-7); 1881.3 produced 7 colonies from 
5xl07 cells (l.4x10-7); 1881.4 produced 2 colonies from 2xl08 cells (lxlo-8). Other 
HGPR T- cell lines were not tested. Finally, GPT- revertants can be selected from 
GPT+ transformants by resistance to 6-thioxanthine (100 µg/ml) or 8-azaxanthine 
(100 µg/ml). If the cell is also HGPRT-, 6-thioguanine (5 µg/ml) can also be 
employed. 
Transformation 
Cells were transformed by the procedure of Graham and van der Eb ( 1973) as 
modified by Oi et al. (l 983). Vigorous cell growth was important for high 
transformation efficiency. Cells in early log phase growth (l-2xto6 cells/ml, 4xl08 
cells total) were placed in centrifuge tubes with a l ml underlay of calf serum. The 
cells were pelleted ( l 00 rpm x l 0 minutes), resuspended in 50 ml of warm 
Dulbecco's modified Eagle's medium, and pelleted onto a l ml cushion of calf serum 
as before. The washed cells were resuspended in a DNA calcium phosphate mixture 
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that was prepared as follows. To 2.5 ml of a hepes buffered solution (50 mM hepes, 
280 mM sodium chloride, pH 7 .10) was added 50 µl of a 70 mM solution of sodium 
phosphate pH 6.8. In a separate tube, 300 µl of sterile 2M calcium chloride was 
added to 100 µg of DNA (e.g. 5 µg pugamma9, 5 µg B6beta2u, and 90 µg genomic 
1881.l carrier DNA) dissolved in 2.2 ml sterile water. The first solution was added 
dropwise to the second solution while bubbling. After thirty minutes at room 
temperature, the DNA had formed a fine white precipitate and was added to the 
cells directly. The resuspended cells were incubated at 37°C for 30 minutes, 
diluted with l 00 ml of l 0% fetal calf serum in Dulbecco's modified Eagle's medium 
and incubated at 37°C for 24 hours. Next, the cells were pelleted through a l ml 
cushion of calf serum and plated in RBF 10 at 5x 10
5 cells/well in 24 well dishes. 
After one day, the medium was replaced with media containing l µg/ml MPA, 250 
µg/ml xanthine and l 5 µg/ml adenine. Half of the medium was replaced every 3 
days. Colonies appeared after two to three weeks. 
Radioimmune assay 
The procedure of Pierres et al. (1981) was followed. Cells were pelleted and 
resuspended at 107 cells/ml in dilution buffer (0.2% fetal calf serum, .02% sodium 
azide in PBS). Monoclonal anti-C57Bl/6 beta2 microglobulin (NEN) was diluted 
1:100 into dilution buffer and spun in an eppendorf centrifuge for 15 minutes to 
pellet insoluble matter. In a 96 well microtiter dish were mixed 20 µof cells (2xl05 
cells) and 50 µl of diluted antibody. The cells were incubated for 1 hr at 4°C and 
pelleted (2400 rpm x 3 minutes, Beckman J6 centrifuge). The pellet was washed 
three times in dilution buff er by resuspending the pellet in 100 ul of dilution buff er 
and pelleting as before. The washed pellet was resuspended in 50 ul of dilution 
buffer containing 1 o5 cpm of 125r-protein A (NEN). The cells were washed three 
times in dilution buffer as before and then counted. Spleen cells from C57Bl/6 
mice were used as positive controls; 1881 cells were used as negative controls. 
56 
Molecular cloning 
Normal procedures were done in normal ways. Genomic DNA from J 1 was 
partially digested with Sau3A and cloned into Eco Rl and Barn HI cut Embl3 DNA. 
After packaging, 3xl06 independent recombinant phage were obtained. Clones 
containing a pBR322 origin of replication and beta-lactamase gene were isolated in 
one step as phasmids. Approximately 107 pfu from separate aliquots of the 
amplified library was used to infect E.coli strain SS13, which is lysogenic for phage 
lambda. Colonies from ampicillin plates were picked, streaked and individual 
colonies were grown to stationary phase in L broth supplemented with 50 ug/ml 
ampicillin. A portion of the culture was lysed by the addition of a small amount of 
chloroform. The phage titer of the supernatant was typically 108 pfu/ml. 
Subsequent analysis of the phage indicated that all contained switch vector 
sequences. Clones lacking functional pBR322 sequences were obtained by screening 
nitrocellulose filters with SV2GPT as a probe. Genomic DNA from the revertant 
J 1.8 was completely cut with Hind III and 11 kb fragments were isolated from a low 
melting temperature agarose gel. The fragments were cloned in lambdaNM762 and 
screened using SV2GPT as a probe. 
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Table l 
Frequency of reversion of GPT+ transformants 
Cell line clones/ cells frequency 






lA. Experimental protocol. left: Immunoglobulin class switching normally 
rearranges Su and Sgamma2b regions thereby deleting the Cu gene segment and 
switching from IgM to IgG 2b expression. right: Rearrangement of the switching 
vector will delete the SV2GPT gene and switch from GPT+ to GPT-. 
lB. Restriction map of pugamma9. The germline Cu gene segment, the 
germline Cgamma2b gene segment and the pSVOD vector, are shown with the 
immunoglobulin class switching vector pugamma9. R = Eco R 1, H = Hind III, B = 
Barn H 1, Sl = Sal I, S = Sac I, 0 = Bgl II, X = Xba I. 
2. Southern blotting analysis of GPT+ transformants. 20 µg of genomic DNA 
was cut with Eco Rl, electrophoresed on 0.8 agarose gels and blotted onto 
nitrocellulose. The filters were hybridized to probe (10 ng/ml) in formamide 
hybridization buffer. Location of bands (in kb) of size markers appear on the left. 
A. The pSV2GPT plasmid was used as a probe. B. A 3.8 kb Eco Rl fragment, 
containing the gamma2b repeat and the Sgamma2b region was used as probe. The 
bands due to the endogenous sgamma2b region, the vector-derived sgamma2b 
region and the pSVOD vector are indicated on the right. Although not seen here, in 
other experiments the F 1 and J 1 cell lines showed an Eco R 1 band at 3.5 kb when 
hybridized to pSVOD. 
3. Restriction map of lambda] 1-4 and lambda] 1-2. Only the inserts are 
shown. See figure lB for restriction site symbols. 
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4. Southern blot analysis of the revertants. Southern blots were performed as 
described in figure 2. Source of DNA appears at the top. Restriction enzyme and 
probe appear at the bottom. 
5. Northern blot analysis of the revertants. 5 µg/lane of poly A+ RNA was 
electrophoreses on l % agarose, 5.5% formaldehyde gels, blotted onto nitrocellulose 
and hybridized to SV2GPT probe. Source of RNA appears at the top. 
6. Restriction map of lambda] 1.8-2. Genomic DNA from J 1.8 was cut with 
Hind III and 11 kb fragments were purified from a low melting temperature agarose 
gel. These fragments were cloned in lambdaNM762 and screened using SV2GPT as 
probe. The partial restriction map of the insert in lambda] 1.8-2 is shown. 
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Chapter 5 
Growth regulation of c-myc gene expression 
in normal lymphocytes 
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Introduction 
Most murine plasmacytomas contain translocations between chromosomes 12 
and 15 (Harris et al., 1982; Calame et al., 1982; Klein, 1981). The breakpoint on 
chromosome 12 is in one of the switch regions of the immunoglobulin heavy chain 
genes and the breakpoint on chromosome 15 is near or within the c-myc gene 
(Marcu et al., 1983; Crews et al., 1982; Adams et al., 1983; Shen-Ong et al., 1982; 
~ 
Taub et al., 1982). The c-myc gene is the cellular homologue of the oncogene found 
in the genome of the myelocytomatosis 29 retrovirus. Rearrangements of this gene 
are not observed in normal B lymphocytes. Evidently immunoglobulin class 
switching, which produces breakpoints in the switch regions, can uncover the 
oncogenic potential of c-myc by an aberrant rearrangement which juxtaposes the 
immunoglobulin switch region with the c-myc gene. 
Structural studies of the normal and oncogenic c-myc genes have determined 
the following. First, the normal c-myc gene has three exons. Although the fir st 
exon is untranslated, it may regulate gene expression at the translational level 
since it contains sequences complementary to sequences near the AUG start codon 
in the second exon (Saito et al., 1983). As a result of base pairing between these 
two RNA sequences, a stem loop structure may form under certain circumstances 
which may regulate translation. Second, the c-myc gene is usually rearranged in 
murine plasmacytomas and the rearrangement breakpoint usually removes the first 
exon (Stanton et al., 1983; Crews et al., 1982; Adams et al., 1983; Saito et al., 1983; 
Taub et al., 1982). The remaining exons are expressed by cryptic promoters present 
in the first intron. In some cases, these promoters express high levels of c-myc 
suggesting that an increased quantity of gene product is crucial in tumorigenesis 
(Shen-Ong et al., 1982; Adams et al., 1983; Marcu et al., 1983; Mushinski et al., 
1983). Finally, the amino acid sequence of the c-myc gene product is occasionally 
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altered by somatic point mutations in the gene (Rabbitts et al., 1984; Saito et al., 
1983; Taub et al., 1983). These mutations may possibly be due to the same 
mechanism which mutates antibody genes. This result suggests that altered type of 
gene product may be important in tumorigenesis. 
In addition to these structural studies, questions can be asked about the 
function of c-myc in both normal development and tumorigenesis. The transformed 
phenotype may not be due solely to the oncogenic activation of c-myc since murine 
plasmacytomas may also contain mutated c-mos, c-ras, and B-lym genes (for a 
review, see Varmus, 1984). One possibility is that the transformed phenotype is due 
to the concurrent action of several oncogenes and if so, the component of the 
phenotype due to c-myc is unknown. Another possibility is that, through a "hit and 
run" mechanism, some oncogenes were used early in oncogenesis but are no longer 
functional in the final tumor. If used early, the c-myc gene may not have any 
function in the final tumor; alternatively, c-myc may be the only oncogene left 
functioning. It would be extremely useful to observe either a normal cell with the 
activated c-myc gene alone (e.g. Land et al., 1983) or a plasmacytoma deprived 
only of the activated c-myc gene (e.g. using antisense RNA as in chapter 6). 
In the work presented here, we have studied c-myc gene expression in normal 
B lymphocytes in order to possibly gain insight into its cellular function. First, the 
pattern of c-myc expression in proliferating and non-proliferating lymphocytes was 
analyzed. It was shown that c-myc expression is increased when normal B and T 
lymphocytes are stimulated to proliferate. Since the expression of this oncogene 
correlates with proliferation, it may possibly function in regulating normal cellular 
proliferation. When expressed from novel promoters in plasmacytomas, 
uncontrolled proliferation may result. 
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One way in which c-myc could regulate cellular proliferation is that it could 
signal for continued passage through the cell cycle. For example, the c-myc gene 
product may be required at a particular point in the cell cycle in order for the cell 
to enter the next phase. If the gene product acts as a "gate", thereby deciding 
whether or not the cell can continue through the cell cycle, its expression may be 
limited to the particular phase of the cycle in which it functions. Accordingly, 
expression of c-myc in cells enriched for various phases of the cell cycle was 
analyzed. In normal, proliferating B cells, expression of the c-myc, immunoglobulin 
Cu and actin genes were all similar in different phases of the cell cycle. Thus, it 
appears that c-myc gene expression is not controlled within the cell cycle. 
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Results 
The bacterial mitogen, lipopolysaccharide (LPS), and the plant lectin, 
concanavalin A (Con A), cause polyclonal proliferation of B and T lymphocytes 
respectively. As shown in figure l, c-myc expression increases when lymphocytes 
are stimulated with either LPS or Con A. Spleen cells were stimulated for 0, l, 2, 3 
or 4 days in 50 ug/ml LPS or l 0 ug/ml Con A. Poly A+ RNA was isolated from 
these cells, electrophoresed on a l % agarose, 5.5% formaldehyde gel, blotted onto 
nitrocellulose and hybridized to a c-myc cDNA probe. In either LPS-stimulated B 
cells or Con A-stimulated T cells, expression of c-myc was at least 20 fold higher 
than in non-stimulated spleen cells. This result indicates that c-myc expression is 
growth regulated. 
Sometimes, genes that are expressed in growing but not resting cells are also 
preferentially expressed at a specific point within the cell cycle of proliferating 
cells. Examples include the human chromosomal thymidine kinase gene and the 
murine dihydrofolate reductase gene (Bradshaw, 1983; Leys and Kellems, 1981). 
Furthermore, cell cycle control of normal c-myc expression might explain why the 
rearranged c-myc gene may become oncogenic even when expressed at low levels. 
In many plasmacytomas, the rearranged c-myc gene is poorly expressed raising 
questions regarding the cause of activation of this oncogene. One possibility is that 
the normal promoter is under cell cycle control whereas the cryptic promoter is 
not. In this model, any expression of c-myc, at the wrong time in the cell cycle, 
can lead to continued passage through the cell cycle and thus uncontrolled cellular 
growth. 
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In order to test this model, lymphocytes enriched for various phases of the 
cell cycle were prepared and c-myc RNA expression was analyzed. Serum 
starvation, metabolic inhibitors, and elutriation are techniques capable of enriching 
for cells in a given part of the cell cycle . We chose elutriation because only it 
leaves cell growth undisturbed. Elutriation separates cells primarily by size. Non-
stimulated lymphocytes, stimulated lymphocytes and macrophages are each of a 
distinct size. Since cell size increases constantly through the cell cycle, the 
subpopulation of stimulated lymphocytes can be further divided so that each each 
fraction contains cells highly enriched for a particular phase of the cell cycle. For 
each fraction, the phase in the cell cycle of individual cells was determined by 
staining with the dye mithramycin, which stains DNA quantitatively. Subsequent 
analysis by flow cytometry can accurately determine the DNA content of single 
cells in each fraction. 
As seen in figure 2, cells present in earlier fractions of e lutriated cells 
contain half as much DNA as cells present in later fractions. This observation 
indicates that the earlier fractions contain cells in the Gl phase and the later 
fractions contain cells in the G2 and M phases. Cells from intermediate fractions, 
with a DNA content between ln and 2n, are in the S phase. RNA was prepared 
from the fractions predominantly containing cells in the G 1, S and G2 + M phases. 
The presence of c-myc RNA was assayed by Northern blotting. Total RNA was 
fractionated on a l % agarcise, 5.5% formaldehede gel, blotted onto nitrocellulose 
and hybridized to a c-myc cDNA probe. As internal controls, the immunoglobin Cu 
and the cytoplasmic act in RNA levels were measured. As can be seen in figure 3, 
these genes all show a comparable pattern of expression in which the band in the 
lane containing G2 + M phase RNA is strong and the band in the lane containing G l 
phase RNA is weak. Either these genes are expressed predominantly in the G2 + M 
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phases or unequal amounts of RNA were inadvertantly added to the three lanes. In 
either case, the pattern of c-myc expression does not differ from either Cu or act in 
expression throughout the cell cycle. 
Discussion 
One of the results presented in this report shows that c-myc gene expression 
is increased when splenocytes are stimulated to proliferate with either LPS or Con 
A. It appears that c-myc preferentially functions in proliferating rather than in 
non-proliferating lymphocytes. These results were subsequently confirmed 
elsewhere (Kelly et al., l 983; Campisi et al., 1984). Explicitly, from these 
experiments it has not been shown that c-myc gene expression causes 
proliferation. 
However, the causative role of c-myc in proliferation has been strongly 
suggested by the following experiment. If normal fibroblasts are transformed with 
the rearranged c-myc gene, they become immortalized as they are capable of 
indefinite proliferation (Land et al., l 983). This result implies that c-myc can 
cause cellular prolif era ti on and thus acts at the "establishment" step in 
tumor igenisis. 
The c-myc gene product might function by controlling the cell cycle; cells in 
the GO phase are induced to enter G l and cells in the G l phase are allowed to 
continue to the S phase. If this model is correct, then c-myc might function at a 
specific phase of the cell cycle and its expression might be limited to that 
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particular point. One advantage of this model is that it could explain the following 
observation. Some plasmacytomas have rearranged c-myc genes which are 
expressed at low levels (e.g. l RNA/cell for 38Cl3 or Ml67, unpub. obs.) suggesting 
that some c-myc genes can be oncogenic even if expressed at low levels. Although 
there are alternatives, an attractive possibility is that c-myc is normally expressed 
at only a certain time in the cell cycle and that any amount of aberrant expression 
at other times allows the cell to proliferate in an uncontrolled manner. In this 
case, rather than overexpression, the cause of oncogenic activation would be 
expression at the wrong time in the cell cycle. 
In order to test this hypothesis, the pattern of normal c-myc gene 
expression was analyzed at different points of the cell cycle in proliferating 
lymphocytes. When RNA from fractions enriched for certain phases of the cell 
cycle was analyzed by Northern blot analysis, it was observed that c-myc 
expression did not differ from either Cu or actin expression. All three sequences 
hybridized more strongly to RNA from cells enriched in the G2 + M phase than to 
RNA from cells enriched in the G l phase. Either all three genes are expressed 
predominantly in the G2 or M phases or more RNA was inadvertantly loaded onto 
this lane. In either case, it does not appear that the level of c-myc gene expression 
within the cell cycle differs from the level of expression of these other genes. 
One possible caveat to these results is that these experiments were 
performed on populations of spleen cells. It is possible that the difference in c-myc 
expression is not due to the difference between growing versus non-growing cells 
but rather due to the selective outgrowth of cells which always express c-myc. 
This possibility is unlikely since cells which are stimulated by LPS or Con A already 
comprise a significant fraction (40%) of splenocytes so that their selective 
outgrowth cannot cause the twenty fold difference observed for c-myc expression. 
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Similarly, it can be argued that the cell cycle experiments utilized a 
population of proliferating B cells of an unknown number of types. Mithramycin 
staining indicated that these fractions contained cells most of which were in the 
same phase of the cell cycle. Thus, c-myc cannot be under cell cycle control in all 
cells. However, it is possible that cell cycle regulation of c-myc expression may 
occur in a fraction of these cell types. 
As can be seen in figure 2, although the elutriated fractions were enriched 
for certain phases of the cell cycle, they were not pure. Analysis of the pooled 
fractions showed that the "G l phase" population contained 90% of its cells in the 
Gl phase, the "S phase" population contained 65% of its cells in the S phase (6 fold 
enrichment), and the "G2 + M phase" population contained 40% of its cells in the G2 
or M phases (8 fold enrichment). A large variation in the quantity of c-myc mRNA 
could be easily observed in these enriched fractions. However, this experiment was 
not sufficiently sensitive to detect small variations in expression. 
Materials and Methods 
Isolation of a c-myc cDNA clone 
A c-myc cDNA clone was isolated in the lambda insertion vector lambdagt l 0. 
PolyA RNA from the plasmacytoma Ml67 was primed with oligo dT and converted 
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into double stranded cDNA by conventional techniques. Eco R l linkers were added 
and the cDNA was cloned into Eco R l digested lambdagt l 0 DNA. Out of 5 x 106 
independent recombinants, 12 c-myc cDNA clones were isolated using a genomic c-
myc gene probe. Thus, the rearranged and normal c-myc alleles in the Ml67 
plasmacytoma are expressed at a low level. The recombinant lambdamyc29 had the 
largest c-myc insert and this insert was subcloned into pBR325 at the Eco Rl site. 
The insert is 1.55 kb long and contains exons 2 and 3 of the c-myc gene. This clone 
was used as a probe in the following experiments. 
Mitogenic stimulation of lymphocytes 
Mitogenic stimulation of splenocytes was accomplished by a modification of 
the procedure of Kearney and Lawton (1975). Balb/c mice were sacr ificed by 
· cervical dislocation. The mice were rinsed in ethanol and their spleens were 
removed using scissors and forceps previously dipped in ethanol. The spleens were 
immediately placed in 10 ml of Dulbecco's phosphate buffered saline (PBSA) in a 50 
ml conical centrifuge tube on ice. One spleen contains approximately l 08 B cells 
and 108 T cells. A single cell suspension was made as follow. A 200 mesh stainless 
steel screen was sterilized and placed over a 60 mm tissue culture dish containing 5 
ml of PBSA, 1 mM EDTA (EDTA was added to prevent coaggulation of the cell 
suspension). The spleen was placed on the wire mesh and cut into l cm cubes with 
sterile scissors and forceps. The blunt end of a sterile 5 ml syringe was used to pass 
single splenocytes through the mesh. The PBSA was placed in a sterile tube and the 
cells were collected by centrifugation. The cells were washed once more in PBSA, 
l mM EDT A. The washed cells were placed in RPMI 1640, l 0% fetal calf serum, 50 
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uM betamercaptoethanol (RBF 10 medium). Viable cells were counted in 0.2% 
trypan blue. The cells were cultured at a density of 106 splenocytes/ml. LPS 
(Sigma) or Con A (Sigma) was added at 50 ug/ml or 10 ug/ml respectively. 
Cell cycle synchonization by elutriation 
Elutriation of lymphocytes was accomplished by a modified procedure of 
Rothenberg (1982). The splenocytes from 20 spleens were stimulated with 50 ug/ml 
LPS in vitro for three days yeilding approximately 4 x 109 B lymphocyte blasts. 
These cells were pelleted, washed in PBSA, pelleted and suspended at 4 x l 08 
cells/ml in Ca2+ - and Mg2+ - free Hank's balanced salts solution supplemented with 
5 mM sodium azide and 2.5 mg/ml bovine serum albumen (BSS/BSA). The cells were 
fractionated on a JE-6 elutriator rotor (Beckman) spinning at 2850 RPM. The 
variable flow rate was controlled by a Cole-Parmer Masterf lex pump (Beckman). 
Red blood cells and unstimulated lymphocytes were elutriated with a flow rate 
between 11.8 ml/min. and 19.7 ml/min. Stimulated B lymphocytes appeared when 
the flow rate was between 23.8 ml/min. and 42.2 ml/min. These cells were further 
fractionated into Gl, Sand G2 + M phases which elutriated at 23.8 ml/min. - 26.5 
ml/min., 28.8 ml/min. - 34. l ml/min and 36. l ml/min. - 37 .5 ml/min respectively. 
Macrophages and other large cells elutriated with flow rates of greater than 42.8 
ml/min. The cells were collected in sterile tubes on ice. The DNA content of 
individual cells in each fraction was measured by staining the cells with 
mithramycin and analysis by flow cytometry (Crissman and Tobey, 1974). A small 
portion of each fraction was pelleted and resuspended in 25% aqueous ethanol 
containing 11 ug/ml mithramycin and 15 mM MgC12. After 15 minutes, the cells 
were analyzed by flow cytometry on the fluorescence activated cell sorter. 
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Northern blotting 
Total RNA was prepared by the method of Chirgwin (1979) except that the 
initial homogenates were sonicated to shear chromosomal DNA which improved 
RNA recovery and purity. Total RNA (20 ug) was fractionated on l % agarose, 
5.5% formaldehyde gels . The RNA was blotted onto nitrocellulose, hybr idized to 
radiolabelled pmyc29 probe, washed and autoradiographed. 
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fig. 1. Expression of c-myc in LPS and Con A stimulated 
lymphocytes. Lymphocytes were stimulated ..!..!l vitro for the 
time shown with either 50 ug/ml LPS or 10 ug/ml Con A. RNA 
+ 
was prepared and 5 ug Poly A RNA was analyzed by Northern 
blotting. Also included are RNAs from a pre B cell (1881.1), 
a plasmacytoma (SP2) and a lymphoma (38C13). The blots were 
hybridized to a c-myc cDNA clone (pmyc29). 
fig. 2. Flow cytometry analysis of elutriated cells. 
Elutriation was used to enrich LPS stimulated B cells in 
different phases of the cell cycle. The DNA from the 
enriched fractions was stained with mithramycin and analyzed 
by flow cytometry. A. fraction enriched for Gl cells. B. 
fraction enriched for S cells. C. fraction enriched for G2 
and M phase cells. 
fig. 3. Northern blot analysis of c-myc, C , and actin gene 
u 
expression in different phases of the cell cycle. RNAs from 
the fractions shown in fig. 2 were prepared. 20 ug of total 
RNA was electrophoresed on a formaldehyde gel and blotted. 
The origin of the RNA is shown at the top; tot refers to the 
total population of cells before elutriation. The filters 
were sequentially hybridized with c-myc, C and actin as 
u 
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We have investigated the feasibility of using antisense RNA to diminish the 
level of a given gene product in a specific and stable fashion. The experiments are 
based on the idea that antisense RNA might be capable of hybridizing to mRNA (or 
its precursor) in vivo, thereby rendering it biologically inactive. As a test case, we 
have attempted to reduce thymidine kinase (TK) activity in cultured mammalian 
cells. Antisense TK RNA was expressed as part of a chimeric dihydrofolate 
reductase-antisense TK transcript. These antisense genes were introduced by DNA 
cotransformation into a mouse L cell line which expresses thymidine kinase 
constitutively. These transformants were then selected for progressively higher 
resistance to methotrexa te, provided by overproduction of dihydrofola te reductase 
(DHFR). The result of this selection procedure was a concomitant increase in 
antisense TK RNA concentration, owing to its presence on the same transcription 
unit as DHFR. In this manner, cells expressing 5,000 to 10,000 antisense molecules 
per cell were obtained. 
In several cell lines expressing high levels of antisense TK RNA, thymidine 
kinase enzyme activity was reduced by eighty to ninety percent. One such line was 
characterized at the molecular level, and it was found that RNA:RNA duplexes 
could be detected in the nuclear RNA fraction. In addition, sense TK RNA is 
present in these cells at a level that is equal to or greater than the level in parental 
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TK+ cells, but it is predominantly localized to the nucleus. These results suggest 
that antisense RNA hybridizes with sense TK RNA in the nucleus. The duplexes fail 
to enter the cytoplasm with normal efficiency, and as a consequence, the amount of 
TK message available for translation is reduced. 
Introduction 
Molecular cloning and DNA sequencing procedures have permitted the 
isolation and characterization of a formidable array of genes from higher 
eukaryotes. Despite the detailed structural knowledge provided by sequence 
analysis of such genes, the functions of their protein products remain, in many 
cases, incompletely understood and in some instances entirely unknown. To analyze 
further the cellular function of a cloned gene, several approaches may be taken. 
These include altering either the type or the amount of gene product expressed in 
VlVO, 
In DNA mediated gene transfer experiments, the expression of a gene can be 
increased in cells which do not otherwise express it or express it at a low level. 
These experiments can be instructive when the addition of gene function gives rise 
to a detectable phenotypic change in the recipient cell or organism. 
An important complementary approach is to specifically eliminate the gene 
product of interest or block its function. In addition to classical genetic methods, 
the task of establishing the null or hypomorphic phenotype has been undertaken 
using two molecular techniques. One elegant molecular approach employs 
antibodies which, when introduced into cells, appear to specifically inhibit the 
function of the protein(s) against which they are directed (Mabuchi and Okuno, 
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1977; Yamaizumi et al., 1978; Antman and Livingstone, 1980; Lin and Feramisco, 
1981; Burke et al. 1984; Warner et al., 1984). However, this technique may be 
limited in its generality. In some cases, the immune reagent may be ineffective 
due to differences in subcellular compartmentalization of antigen and antibody. 
Moreover, when antibody binding does occur, it ma y fail to neutralize protein 
function. 
A second molecular approach involves antisense nucleic acids. In this case, 
the hypothesis is that sufficiently high intracellular concentrations of nucleic acids 
complementary to a given messenger RNA species will hybridize with that mRNA 
(or its precursor) in vivo, and that such hybridization will ultimately inhibit 
synthesis of the protein product. 
There are a number of observations that suggest that this hypothesis may be 
correct. For example, in E.coli, expression of the ISlO transposase gene (Simons 
and Kleckner, 1983) and the Omp F gene (Mizuno et al., 1984) are apparently 
regulated at the translational level by antisense RNAs. Also, the activity of an 
RNA which serves to prime replication for the Col E 1 plasmid appears to be 
reduced by annealing with a complementary RNA (Tomizawa et al., 1981). These 
results indicate that antisense RNAs may exert regulatory effects by hybridizing 
with their complements in vivo. Nevertheless, it is important to recognize that 
proteins may play an important part in mediating these hybridization events (e.g. 
see Tomizawa 1984). 
It is then of interest to test whether antisense nucleic acids can generally be 
employed to reduce the activity of a specific gene. In E. coli, expression of 
antisense IPP, Omp A, Omp C and lac Z RNAs reduced the cellular concentration of 
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the corresponding proteins (Coleman et.al. 1984; Pestka et al., 1984). In frog 
oocytes, injection of antisense globin RNA into the cytoplasm inhibited synthesis of 
globin from microinjected beta globin messenger RNA (Melton, 1985). It was shown 
that RNA:RNA duplexes formed in the oocyte after microinjection, suggesting that 
RNA hybridization was instrumental in establishing the observed block in globin 
protein synthesis. One important implication of these results is that the 
introduction of a pulse of antisense RNA may be useful in preventing the onset of 
expression from a particular gene in early embryogenesis. For example, 
microinjection of antisense kruppel RNA appears to cause a defect in Drosophila 
embryo segmentation which is analogous to defects caused by mutations in the 
kruppel gene (Rosenberg et al., 1985). 
In mammalian cells, an important initial observation was reported by Izant 
and Weintraub (1984). Microinjection of TK genes into mammalian cells typically 
results in a burst of TK synthesis which can be monitored by a single cell 
autoradiographic assay for incorporation of 3H-thymidine. If the recipient cells 
also contained an excess of genes coding for antisense TK RNA, a large diminution 
in TK expression from the injected thymidine kinase genes was observed. The 
observed reduction in transient thymidine kinase expression was shown to be 
dependent on sequence complementarity between sense and antisense RNA genes, 
as would be predicted if the reduction in enzyme activity is mediated by antisense 
RNA hybridization. Since this experimental approach is confined to small cell 
numbers, direct investigation of the mechanism of enzyme depression is 
precluded. Furthermore, if this approach is to be generally applicable, the effect 
of antisense RNA should not be limited to a transient reduction of the activity of 
microinjected genes. 
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Our objectives are to develop a general protocol for the stable reduction of a 
given gene product in mammalian cells. Toward these objectives, we believe that 
the following points are relevant. First, an approach based on production of 
antisense RNAs from genes stably located in each cell's nucleus is desirable. An 
advantage of endogenous antisense production is that any effect that it may 
generate will be evident in a large population of cells, permitting examination at 
the biochemical level. Second, it will be important to be able to reduce the 
activity of resident chromosomal genes because these will most often be the 
targets of interest for studies utilizing antisense RNA. Third, it is expected that 
antisense RNA should inhibit the synthesis of specific proteins. Therefore, 
inhibition must be maintained long enough to allow for the disappearance of any 
pre-existing protein. This means that a pulse of antisense RNA will be ineffective 
in any case in which the antisense RNA degrades more rapidly than the protein 
product. Finally, it would be advantageous to express the antisense RNA from an 
inducible promoter so that the reduction in protein level could be made conditional. 
In the work presented here, sense and antisense Herpes virus TK genes were 
stably introduced into mouse L cells where they expressed TK mRNA and antisense 
TK RNA respectively. At high concentrations of antisense TK RNA, thymidine 
kinase activity was stably diminished in several cell lines. Analysis of RNA 
extracted from one such cell line revealed that double stranded TK RNA is present 
in the nuclear compartment. Furthermore, the level of sense TK RNA in the 
cytoplasm is much lower for these cells than in parental TK+ cells. Based on these 




Initial antisense genes are not expressed when transfected into cells 
One straightforward way to synthesize antisense RNA is to invert a coding 
region sequence relative to its promo tor. In preliminary experiments, antisense 
dihydrofolate reductase or thymidine kinase sequences were inserted between the 
metallothionein promoter and a metallothionein intron and polyadenylation addition 
site. The metallothionein gene was chosen because transcription can be induced by 
heavy metals, so that the expression of antisense transcripts could be regulated. 
Each of these recombinant genes was introduced into TK+ L cells by DNA mediated 
gene transfer. Analysis of the L cell transformants containing either of these 
antisense genes suggested that neither TK nor DHFR activity was significantly 
reduced upon induction with heavy metals. Surprisingly, little or no antisense DHFR 
or TK RNA was detected in RNA blotting experiments (S. Kim, unpub. obs.). 
In these initial experiments, a major problem was a failure to accumulate 
significant quantities of antisense RNA. It is known that numerous chimeric genes 
containing the metallothionein promotor direct the synthesis of high levels of 
messenger RNA under induction conditions similar to those tested here (Mayo et 
al., 1982). A particularly relevant example is vector pMD (figure 1), which contains 
the complete DHFR protein coding sequence in sense configuration f tanked by 
promotor and 3' sequences from the metallothionein gene. Unlike the analogous 
gene containing DHFR sequences in the antisense orientation, substantial levels of 
mRNA are produced upon heavy metal induction of cells containing the pMD 
plasmid (P. Mueller and B. Wold, to be presented elsewhere). Taken together, 
these results suggest that the failure to accumulate antisense transcripts may be 
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due to post-transcriptional events such as aberrant processing, transport or 
turnover. 
Design of Amplifiable Antisense RNA Genes 
As an alternative to the simple antisense genes described above, a second 
generation of plasmids were designed which we expected would ultimately produce 
higher steady state levels of antisense RNA. These genes contain the dihydrofolate 
reductase protein coding region (in the sense orientation) followed by antisense TK 
sequences (figure l ). RNA transcribed from these chimeric genes is expected to be 
bifunctional, directing the synthesis of an enzyme, DHFR, and providing antisense 
TK RNA. The level of DHFR can be significantly increased, usually by means of 
gene amplification, by selecting cells resistant to the drug methotrexate (M tx; for a 
review, see Stark and Wahl, 1984). Since antisense TK sequences appear on the 
same RNA as DHFR sequences, selection for cells resistant to high levels of Mtx 
should result in the production of large amounts of antisense TK RNA. If antisense 
TK RNAs are capable of hybridizing with sense TK RNAs in vivo, then it would be 
expected that the level of TK activity will decrease as the concentration of 
antisense TK RNA increases. 
In these experiments, three antisense genes were employed (figure 1). The 
parental plasmid, pMD, contains a gene consisting of a metallothionein promoter, 
DHFR coding region, metallothionein intron and metallothionein poly A addition 
site. DNA fragments containing thymidine kinase sequences were inserted into the 
3' untranslated region in inverted orientation relative to the DHFR sequences. 
Thus, transcription originating from the metallothionein promoter would be 
expected to produce a messenger RNA coding for reductase and containing 
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antisense TK sequences. The first plasmid, pMDKT 1, contained a 1.1 kb fragment 
derived from the TK gene. This fragment, also used by Izant and Weintraub ( 1984), 
includes 53 base pairs encoding the 5' untranslated region of the TK mRNA and all 
of the protein coding sequence except the carboxy terminal 23 bases. The second 
vector, pMDKT2, was constructed by deleting a central fragment (denoted segment 
B) from the TK sequences in pMDKT l leaving behind a 30 l bp fragment from the 5' 
portion (segment A) and a 225 bp sequence from the 3' portion of the TK gene 
(segment C). The third vector, pMDKT3, has been further deleted. It retains only 
the terminal 225 base pair fragment (segment C) corresponding to the carboxy 
terminus of thymidine kinase, and possesses a reduced 3' untranslated region from 
the metallothionein I gene. The transcripts expected to be produced from each of 
these genes are also indicated in figure 1. 
Introduction of antisense vectors into TK + L cells 
In order to construct a parental thymidine kinase positive cell line in which 
ahtisense TK genes would subsequently be tested, DNAs containing TK and adenine 
phosphoribosyl transferase (APR T) genes were introduced into L APR T- TK- cells 
by DNA mediated gene transfer (Wigler et al. 1977). A mixture of 1 ug pTK DNA, 
0.1 ug pAPRT DNA, and 20 ug carrier DNA was added as a calcium phosphate 
precipitate per 100 mm plate. Genes that are transfected into cells in culture are 
not as stable as endogenous genes; the rate of phenotypic reversion for cells 
containing a gene introduced by DNA transfer can be two to five orders of 
magnitude hig~er than the mutation rate for endogenous genes (Pellicer et al., 
1980). For example, transfected TK genes may revert at a frequency of 10-l to l 0 
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-4 revertants/cell. A high frequency of spontaneous reversion of thymidine kinase 
positive cells to the TK negative phenotype would obviously complicate 
interpretation of any reduction in TK activity in the presence of antisense TK 
RNA. To ameliorate this problem, the APR T gene was included. If a second gene 
is cotransfected with TK, i.e. APRT, both genes appear to integrate into the same 
chromosomal location and selection for the second gene often reduces the 
frequency of spontaneous reversion of the first gene (Roberts and Axel, 1982). 
Accordingly, cells expressing APR T were selected and ten clones were isolated. 
Seven of the APR r+ clones were also TK +. One of the seven clones reverted from 
APRT+, TK+ to Aprt+, TK- at a frequenc y less than 10-5 revertants/cell in three 
independent experiments. This frequency of reversion is sufficiently low that 
thymidine kinase activity is expected to be unaffected by the accumulation of 
spontaneous TK revertants. Therefore, this clone, designated P, was used as the 
parental cell line into which antisense TK vectors were introduced. In all 
experiments that follow, P cells were grown in media which imposes selection for 
APRT. 
Next, the pMD control vector and the antisense plasmids were each 
introduced into the parental cell line by DNA mediated gene transfer. To each 100 
mm plate of parental cells was added l ug pNE03 DNA, 10 ug carrier DNA and 10 
ug of pMD, pMDKT 1, pMDKT2, or pMDKT3 DNA as a calcium phosphate 
precipitate. The pNE03 vector (B. Wold and R. Axel, unpub. results) expresses a 
bacterial enzyme which allows mammalian cells to grow in the presence of the drug 
G418 (Southern and Berg, 1982). Transformants were selected by growth in G418 
yielding several hundred colonies per plate. Transformants from each plate were 
subsequently pooled. Five plates of parental cells were transfected with pMDKT l 
resulting in five pools of transformants designated KTl-A to KTl-E. Similarly, 
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cells transfected with pMDKT2 yielded KT2-A to KT2-E, cells transfected with 
pMDKT3 gave KT3-A to KT3-E and cells transfected with pMD were designated 
KTO-A to KTO-C. 
Low levels of antisense TK RNA do not affect thymidine kinase activity 
As expected, all of the transformants exhibited increased levels of 
resistance to methotrexate relative to parental cells indicating that the newly 
transfected genes were capable of expressing dihydrofolate reductase, as 
expected. Prior to transfection, the parental cell line was resistant to 10 nM Mtx 
whereas cells containing the DHFR chimeric genes were immediately resistant to 
elevated levels of methotrexate: KT l cells were resistant to 50 nM MTx, KT2 cells 
were resistant to 150 nM MTx and KT3 and KTO cells were resistant to 300 nM 
Mtx. The varying levels of resistance to methotrexate indicate that differing 
amounts of DHFR are expressed in cells transfected with each vector. KT l cells 
were resistant to the lowest levels of Mtx suggesting that the inclusion of the full 
l.l kb antisense TK sequence in pMDKTl interfered with DHFR expression. 
Conversely, KT3 cells were resistant to as much Mtx as KTO cells indicating that 
the inclusion of the 225 bp fragment in pMDKT3 did not significantly affect DHFR 
expression. 
Does expression of antisense TK RNA in these primary transformant 
populations have any effect on the thyrnidine kinase phenotype? To answer this 
question, TK enzyme activity was quantitated in KTO, KTl, KT2 and KT3 cells. 
The data presented in table l, accurate to within 10%, show that the level of TK 
activity in these cells was unchanged relative to the parental thymidine kinase 
positive cell line (see Materials and Methods). 
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Selection for methotrexate resistance results in increased levels of antisense TK 
RNA 
It was expected that selection for Mtx resistance would often yield cells that 
express elevated levels of dihydrofolate reductase, provided by high levels of 
DHFR-antisense-TK RNA. Resistance to Mtx was gradually increased by 
successive rounds of selection in twofold greater drug concentrations (Alt et.al. 
1978). To establish that selection for methotrexate resistance resulted in elevated 
levels of antisense containing transcripts, RNA was extracted from KT3-B-.3, KT3-
B-2 and KT3-B-64 cells, which are resistant to 0.3 uM Mtx, 2 uM Mtx and 64 uM 
Mtx respectively (the level of resistance to Mtx in uM units is indicated following 
the dash in each cell name). These RNAs were analyzed for the presence of 
antisense TK RNA using an RNAse protection assay. Radioactively labeled TK 
RNA was synthesized in vitro using an SP6 transcription system (Melton et al., 
1984). This probe was hybridized to cellular RNA and unhybridized probe was 
digested with RNAses A and T 1, which are specific for single stranded RNA. The 
protected probe was melted and analyzed by fractionation on a denaturing 
polyacrylamide gel. As seen in figure 3, approximately fifty to one hundred times 
more antisense TK RNA is made in cells resistant to 64 uM Mtx than in cells prior 
to selection for Mtx resistance. Similarly, in KT2-E cells, it was found that 
selection for Mtx resistance resulted in a large increase in the expression of 
antisense TK RNA (data not shown). Therefore, as expected, selection for 
resistance to methotrexate resulted in increased concentrations of DHFR-
antisense-TK RNA in cells transfected with either pMDKT2 or pMDKT3. 
Examination of genomic DNA isolated from parental cells, initial transformants and 
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cells resistant to 64uM Mtx showed that the predominent means of generating 
higher levels of DHFR-antisense-TK RNA was by amplification of gene number 
(data to be presented elsewhere). However, in two independent cases, cells 
transfected with pMDKTl did not produce more antisense TK RNA in response to 
Mtx selection (data not shown). Since these cells did not show a reduction in TK 
activity and since the concentration of antisense TK RNA was not increased by 
methotrexate selection, they were not studied further. 
KT2 and KT3 cells which are resistant to high concentrations of Mtx have lower TK 
activity 
Since stepwise selection for methotrexate resistance resulted in a gradual 
increase in the concentration of antisense TK RNA, it was anticipated that at some 
point the concentration of antisense RNA may become great enough to inhibit 
thymidine kinase expression. To test this possibility, the level of TK enzyme 
activity in KT3 cells was determined at each step of increased Mtx resistance. As 
can be seen in figure 2, there is much less TK activity in KT3-B-64 or KT3-D-64 
cells than in parental cells. Beginning with cells resistant to 4 uM M tx, the level of 
TK activity continually decreased until only 15% or 18% of the enzyme activity 
present in parental cells remained in KT3-B-64 and KT3-D-64 cells respectively. 
The level of TK activity for other transformants before and after Mtx selection is 
shown in table l. Two out of four independent pools of KT3 cells showed a 
significant decrease in TK activity in cells resistant to 64 uM Mtx. Likewise, two 
out of three pools of KT2 cells exhibited reduced TK activity in cells resistant to 
100 uM Mtx. 
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Specificity of antisense RNA effects 
Control experiments showed that the reduction in TK activity in KT2 and 
KT3 cells apparently depends on the presence of antisense TK sequences. The 
plasmid pMD (figure l) is identical to the antisense genes in KT2 and KT3 cells 
except that it contains no antisense thymidine kinase sequences. This plasmid was 
introduced into parental TK+ cells and transformants resistant to methotrexate 
were selected as before. In cells resistant to 64 uM methotrexate, there was no 
detectable reduction in enzyme activity (table 1 and fig. 2). This result suggests 
that the reduction in TK activity observed in several KT2 and KT3 populations 
requires antisense TK sequence and is not an artifact of methotrexate selection. 
A second set of control experiments indicated that the diminution in 
thymidine kinase activity in KT2 and KT3 cells is specific. The level of hexokinase 
activity was determined. Hexokinase catalyzes the first step in glycolysis and was 
chosen because it is easily assayed. As can be seen in table 2, its activity is 
essentially unchanged in cell clones which have as much as a nine fold reduction in 
their level of TK activity. 
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Double stranded RNA is formed in KT3-B-64 cells 
The results presented so far suggest that TK activity can be specifically 
reduced in cells which express high concentrations of antisense TK RNA. We have 
examined one cell population, KT3-B-64, in greater detail. If the reduction in the 
level of thymidine kinase activity is caused by hybridization of sense TK RNA to 
antisense TK RNA, then double stranded RNA might be present at detectable levels 
in these cells. Accordingly, an experime nt designed to assay for the presence of 
double stranded TK RNA was performed. Double stranded RNA was prepared by 
treating RNA samples with RNAses A and Tl. The ribonucleases were removed by 
digestion with proteinase K and the RNAse resistant fraction was denatured and 
hybridized to an RNA probe for sense TK RNA. After hybridization, unreacted 
probe was digested by RNAse A and Tl followed by fractionation on a denaturing 
polyacrylamide gel. As expected, the TK+ parental cell line and TK+ cells 
expressing low levels of antisense RNA contain no detectable double stranded TK 
RNA (figure 4). However, a band was observed when RNA samples from the TK 
diminished population were analyzed. 
Several control experiments show that the protected band in figure 4, lane 3, 
is due to the presence of RNA:RNA hybrids rather than contaminating genomic 
DNA. It is expected that RNA:RNA duple xes will be labile to ribonuclease 
digestion if they are first heat denatured. They also are expected to be labile to 
alkaline hydrolysis. As expected, the 225 nucleotide band observed in KT3-B-64 
RNA is sensitive to both of these pretreatments (data not shown). Furthermore, 
RNA hybrids should be resistant to exhaustive DNAase digestion. The band is 
unaffected by prior treatment of a KT3-B-64 RNA sample with high levels of 
DNAse I (data not shown). We therefore conclude that the observed band is due to 
RNA duplexes in KT3-B-64 RNA. 
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Results of an important control experiment presented in figure 4, lane 1, 
argue that the RNA duplexes detected in KT3-B-64 RNA are formed in vivo and are 
not a product of reassociation during RNA extraction and handling. No double 
stranded RNA was observed when antisense TK RNA was synthesized in vitro and 
added to parental TK + cells at the start of RNA preparation. The amount of 
antisense TK RNA that was added to P cells was equivalent to the amount of 
antisense TK RNA in KT3-B-64 cells (50 ng antisense TK per 100 ug of P cell total 
RNA). This experiment suggests that the double stranded TK RNA in KT3-B-64 
cells did not form during RNA preparation and is probably present in vivo. 
Therefore, the mechanism of inhibition of TK activity may involve the 
hybridization of antisense TK RNA to sense TK RNA. The size of the double 
stranded RNA, 225 base pairs, is the same as the size of antisense TK sequences 
contained in the DHFR-antisense-TK gene of KT3 cells (pMDKT3), suggesting that 
the entire antisense TK RNA sequence is present in the double stranded RNA. 
Double stranded RNA is found in the nucleus but not in the cytoplasm 
One possibility is that hybridization of antisense TK RNA with sense TK 
RNA occurs in the cytoplasm, and reduces thymidine kinase levels by inhibiting 
translation of TK mRNA. Another possibility is that hybridization occurs in the 
nucleus, resulting in inhibition of RNA processing or transport. In order to 
distinguish between these .two possibilities, KT3-B-64 cells were fractionated and, 
from an equivalent number of cells, nuclear and cytoplasmic RNAs were prepared. 
The amount of double stranded TK RNA in each sample of total RNA was measured 
using an RNAse protection assay as outlined above. As shown in figure 4, lanes 4 
and 5, at least 95% of the double stranded TK RNA is confined to the nuclear 
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fraction. The amount of hybrid detected in nuclear RNA samples can account for 
virtually all of the double stranded RNA found in RNA prepared from the entire 
cell. These observations suggest that RNA hybridization may occur predominantly 
in the nucleus. 
In KTJ-B-64 cells, sense TK RNA is present in the nucleus but not in the cytoplasm 
In order to further investigate the cause for diminished TK enzyme activity, 
sense TK RNA in parental cells and KT3-B-64 cells was analyzed. RNA samples 
were melted and hybridized to an RNA probe for sense TK RNA. Unhybridized 
probe was digested with RN Ase A and Tl and the protected probe was analyzed by 
fractionation on a nondenaturing polyacrylamide gel. Since the RNA sample was 
melted before hybridization, this procedure should detect sense TK RNA whether it 
is single or double stranded. As can be seen in figure 5, KT3-B-64 cells show 
similar, if not increased, levels of sense TK RNA when compared to parental cells. 
However, KT3-B-64 cells have eight times less TK activity suggesting that the 
sense TK RNA is inefficiently utilized. In order to explore the basis of this poor 
expression, the abundance of the sense TK RNA in the nuclear and cytoplasmic 
fractions, from equivalent numbers of cells, was analyzed. It was found that in 
KT3-B-64 cells, greater than 95% of the sense TK RNA is localized to the nucleus, 
whereas in parental cells, sense TK RNA is primarily cytoplasmic (fig. 5 and data 
not shown). This result suggests that the decrease in thymidine kinase activity is 
caused by a lack of sense TK messenger RNA in the cytoplasm where it can be 
translated. 
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Only 225 base pairs of TK sequence are in hybrid form in the nuclear RNA of 
KT3-B-64 cells, because there are only 225 bases of antisense sequence in this 
particular antisense gene. However, when the nuclear sense TK RNA is examined, 
the majority is at least 1.1 kilobases in length (this corresponds to the full TK 
sequence assayed by the RNA probe, and constitutes ninety percent of a full-length 
TK transcript). Therefore, once hybridized, the free ends of the single stranded 
sense TK RNA appear not to be degraded much more rapidly than the double 
stranded "core". Quantitation of sense TK and duplex TK RNA was performed by 
excising the relevant bands from gels like those shown in figures 4 and 5, and 
measuring the amount of labelled probe. Given the specific activity of the RNA 
probe, it was calculated that there are 50 to 100 molecules of duplex thymidine 
kinase RNA per cell. Within the limits of the measurement, this accounts for all of 
the sense TK transcript in KT3-B-64 nuclei, and implies that the majority of these 
RNAs are in hybrid form. 
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Discussion 
The results presented here suggest that high levels of cellular antisense TK 
RNA can stably reduce TK activity. Antisense TK sequences were inserted into the 
3' untranslated region of a DHFR gene. One advantage of this approach is that the 
level of antisense TK RNA could be increased by selecting cells which are resistant 
to Mtx. Resistance to high concentrations of Mtx usually involves overexpression 
of DHFR RNA which, in this experiment, also results in an increase in the amount 
of linked antisense TK RNA. Accordingly, vectors capable of producing DHFR-
antisense-TK RNA were introduced by gene transfer into mouse L cells and M tx 
resistant cells were selected. It was found that KT3-B-64 cells, which are Mtx 
resistant, produced approximately one hundred times more antisense TK RNA than 
KT3-B-0.3 cells, which are Mtx sensitive. Therefore, selection for Mtx resistance 
greatly increased the concentration of DHFR antisense TK RNA. As expected, the 
predominant mechanism of increased expression was amplification of the copy 
number of the DHFR-antisense-TK genes (data not shown). 
Thymidine kinase activity was measured in cells which had differing 
concentrations of antisense TK RNA. In several independant cell populations, it 
was found that the level of TK activity diminished as the concentration of antisense 
TK RNA increased. This result is consistent with the view that high levels of 
antisense TK RNA may be responsible for specifically inhibiting TK synthesis. 
The mechanism by which TK activity is reduced in the presence of antisense 
RNA was studied by analyzing the types and amounts of RNA present. First, double 
stranded TK RNA was observed in KT3-B-64 cells, which have decreased TK 
activity, but was not found in KT3-B-0.3 cells or parental cells, which have full TK 
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activity (fig 4 and data not shown). The double stranded RNA was predominantly 
nuclear rather than cytoplasmic. Second, in total RNA, it was observed that KT3-
B-64 cells had as much or slightly more sense TK RNA than do P cells. Since KT3-
B-64 cells have eight times less TK activity than P cells, it is strongly suggested 
that the sense TK RNA in KT3-B-64 cells is poorly utilized. In order to investigate 
this paradox, the abundance of the sense TK RNA was examined in the nuclear and 
cytoplasmic compartments of P and KT3-B-64 cells. It was found that the sense TK 
RNA was at least 95% nuclear in KT3-B-64 cells whereas it was at least 75% 
cytoplasmic in parental cells. 
A model for reduction of TK gene activity by antisense RNA 
Based on these observations, we prefer the following model for the 
diminution of TK activity in KT3-B-64 cells. When the concentration of antisense 
TK RNA becomes sufficiently high, it hybridizes to sense TK RNA. Hybridization 
occurs primarily in the nucleus and the double stranded RNA is poorly transported 
to the cytoplasm. As a result, the level of TK enzymatic activity diminishes 
because relatively less sense TK RNA appears in the cytoplasm where it can be 
translated. 
However, since it is not possible to draw conclusions regarding kinetic 
processes based soley on steady-state measurements such as those presented here, 
there are other models which are consistent with the data. For example, the 
failure to detect cytoplasmic double stranded RNA could be explained by 
cytoplasmic hybridization followed by either transport of the double stranded RNA 
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to the nucleus or its rapid degradation. In addition, it is important to recognize 
that while our results show that the presence of double stranded TK RNA correlates 
with a decrease in TK activity, they do not show that the double stranded RNA is 
the cause of the reduction. Another model which formally explains the results is 
that, for some unknown reason independent of antisense TK RNA, expression from 
the sense TK gene is reduced and double stranded RNA is formed as a secondary 
event. We feel that this last model is improbable for the following reasons. The 
parental cell clone was chosen because of its ability to stably express TK and 
therefore, spontaneous changes in TK activity in five out of eight independently 
derived cell populations from that clone are unlikely. Furthermore, random 
changes in TK activity would not be expected to correlate in independent instances 
with high levels of antisense TK RNA. 
Antisense RNA physiology 
The level of accumulation of antisense TK RNA differed depending on the 
type and amount of antisense TK sequence present in the chimeric gene. Several 
observations made in the course of this study suggest that, in the pMDKTl gene, 
inclusion of a 1.1 kb fragment of antisense TK sequence interfered with the 
accumulation of its transcripts. First, the initial resistance to methotrexate 
following DNA mediated gene transfer with pMDKT 1 is six times lower than the 
resistance obtained with pMD (an identical gene in all respects except that it 
contains no TK sequence). Second, selection for Mtx resistance was much more 
difficult in cells containing this gene than in cells containing DHFR genes with 
smaller segments of antisense TK sequence (pMDKT2 and pMDKT3) or no TK 
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sequence at all (pMD). Finally, when Mtx resistant KTl cells were obtained, the 
antisense TK sequences were not expressed at a higher level but appeared as a 
smear on a Northern blot (data not shown). In contrast, pMDKT2 and pMDKT3 do 
not show this severe interference with DHFR expression. These genes differ from 
PMDKTl in that they lack a central Ava I fragment of the antisense TK gene and 
produce an RNA which is smaller. The reasons for the difference in DHFR 
expression between these vectors are incompletely understood. A practical 
implication is that it may be necessary to identify and remove antisense sequences 
which interfere with the accumulation of antisense RNA on a case by case basis. 
The level of thymidine kinase activity was significantly diminished only when 
a high level of antisense TK RNA was expressed. The approach taken here was to 
express antisense TK sequences as part of a DHFR messenger RNA. This allowed 
us to increase the concentration of antisense TK RNA by selecting for resistance to 
increasing levels of methotrexate. Although this selection scheme resulted in 
increased levels of DHFR-antisense-TK RNA in the cytoplasm, a concomitant 
effect was its increase in the nucleus. The increase in nuclear antisense RNA 
concentration may have been the cause of the reduction in TK activity since, in this 
case, it appears that RNA:RNA hybridization occurred in the nucleus. In KT3-B-64 
cells, there is a steady state level of at least 5,000 antisense TK RNA molecules 
per cell, with about 40% localized in the nuclear compartment and 60% in the 
cytoplasm (figure 3). Thus, in these cells, there is at least 500 fold more antisense 
TK RNA than sense TK RNA. 
The levels of antisense RNA reported here are likely to be significantly 
higher than the amounts reported in the experiments of Izant and Weintraub (1984). 
In that study, the cytoplasmic level of antisense TK RNA was equivalent to the 
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amount of sense TK mRNA. Although the level of nuclear antisense RNA was not 
determined, if it were high, it could have contributed significantly to the observed 
effect on TK activity. Nevertheless, the 500 fold difference in cytoplasmic RNAs 
argues persuasively that there is also a difference in the amount of nuclear 
antisense RNAs. This difference suggests that, to reduce TK activity, more 
antisense RNA is required in this report than in the previous one. The origins of 
this apparent paradox may reside in major differences in experimental approach 
including: translated versus untranslated antisense RNAs, stable versus transient 
inhibition and newly microinjected versus stably integrated TK genes. 
As shown in table 2, the level of TK activity varied in different cell clones 
derived from the KT3-B-64 cell population, ranging from 80% in clone KT3-B.l-64 
to 11 % in clone KT3-B.5-64. One possible explanation for the difference in TK 
activity is that the levels of nuclear antisense TK RNA may fluctuate between 
these clones. Another possibility is that, if the position of chromosomes within the 
nucleus is fixed, RNA hybridization may be more efficient when the antisense TK 
gene is physically close to the sense TK gene because the local concentration of 
antisense TK RNA may be greater. Cells resistant to high levels of methotrexate, 
but with different levels of TK activity, are being studied at the RNA and DNA 
levels to determine the molecular basis for this difference. 
At present, we have only limited data on effects generated by different 
regions of antisense TK sequence. In two previous studies, one in E. coli and the 
other in Xenopus oocytes, it was found that antisense RNA was effective only if 
sequences complementary to the AUG start codon were included (Coleman et al., 
1984; Melton 1985). This supports the idea that the principal effect of antisense 
RNA is exerted at the translational level. Perhaps this is not surprising since, in 
the Xenopus experiments, both sense and antisense RNAs were injected directly 
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into the cytoplasm and in E. coli, transcription and translation are tightly coupled. 
In the animal cell experiments reported here, we have found that antisense 
sequences derived exclusively from the 3' region of TK protein coding sequence are 
sufficient to reduce gene activity. Furthermore, a second antisense gene 
(pMDKT2), which contains sequences spanning the AUG initiation codon in addition 
to the carboxy terminal sequence of pMDKT3, was neither more nor less effective 
in diminishing TK activity than was pMDKT3 alone. It remains to be seen what 
antisense sequences will be most effective in reducing gene activity in this 
experimental system. 
The potential for employing antisense RNA to diminish gene activity 
In particular, this report has suggested that antisense TK RNA can 
significantly diminish thymidine kinase activity; in general, will techniques 
involving antisense RNA be useful to study gene function? It is possible that the 
TK gene is a special case and, in general, antisense RNA will be ineffective in 
inhibiting the expression of other genes. Salient differences between the Herpes 
virus thymidine kinase gene and other genes include the fact that the TK gene was 
introduced into the genome by DNA mediated gene transfer, the gene is relatively 
small ( l.3 kb), and it contains no intervening sequences. However, it is interesting 
to note that, rather than abnormally promote the ease with which antisense RNA 
might inhibit protein production, these characteristics may actually detract from 
its effectiveness. For example, the 3' end of TK mRNA, which was hybridized with 
antisense RNA in these experiments, is the last sequence to be transcribed and 
must therefore have a somewhat shorter nuclear dwell time than upstream 
sequences. In addition, the lack of an RNA splicing step may permit more rapid 
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nuclear transport for TK RNA than for typical spliced RNAs. This line of 
reasoning suggests that RNA transcribed from 5' sequences of large genes 
containing many intervening sequences will likely take longer to be exported from 
the nucleus. Therefore, antisense RNA may be able to hybridize to these sequences 
more efficiently than to 3' sequences from small genes such as TK. 
Another issue regarding the utility of antisense RNA is whether a reduction 
of tenfold in gene activity is sufficient to cause a hypomorphic phenotype. A ten 
fold reduction of TK activity did not render these cells resistant to 
bromodeoxyuridine and therefore TK- as conventionally defined. Thus, this 
technique is not yet useful for establishing the complete loss of function of a 
gene. However, there are some genes which show a phenotypic effect with only a 
partial loss of function. [n genes which exhibit haplo-insufficiency, such as the 
Notch locus in Drosophila, a twofold difference in gene activity yields an altered 
phenotype (Wright, 1970). [n some cases, a hypomorphic phenotype may reveal 
subtleties about the function of a gene product which are not always obvious from 
the null phenotype. For example, a complete lack of the low density lipoprotein 
receptor grossly affects cholesterol metabolism and is usually fatal in childhood 
(Goldstein and Brown, l 983). However, a two fold reduction causes one to become 
prone to premature atherosclerosis and cardiovascular disease. These examples 
suggests that in mammalian cells, there are likely to be many genes which cause a 
change in cellular behavior when their activity is reduced ten fold. Future 
improvements may increase the effectiveness of antisense RNA and may thus 
increase the range of genes for which an analysis using antisense RNA would be 
fruitful. 
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Materials and Methods 
Plasmid construction 
pMD, a gift from P. Mueller, was constructed from the metallothionein I 
gene and the DHFR cDNA (Drunam et al., 1980; Nunberg et al., 1980). A Barn HI to 
Bgl II fragment containing the DHFR cDNA was inserted into the metallothionein I 
gene which had been previously cleaved by Bgl II, located 9 bp upstream of the A TG 
start codon, and Alu I, located in the second exon. The Alu I site in the 
metallothionein gene was converted into a Bgl II site by the addition of Bgl II 
linkers. pMDKTl was made by inserting a 1.1 kb Bgl II to Sma I fragment derived 
from the HSY TK gene into the Bgl II site in pMD after the attachment of a Barn H l 
linker to the Sma l site. pMDKT2 was made by partially digesting pMDKTl with 
Ava I and isolating a plasmid that had the 600 bp Ava I fragment from the middle of 
the TK sequences deleted. pMDKT3 was made by deleting a 1050bp Ava I 
fragment from pMDKT l and recircularizing after treatment with DNA polymerase I 
Klenow fragment. 
Cell culture 
L cells were maintained in Dulbecco's modification of Eagles Medium 
supplemented with 10% calf serum, 10 ug/ml streptomycin sulfate and 60 ug/ml 
penicillin-K (EC 10 media). APRT selection used EC 10 media supplemented with 4 
ug/ml azaserine and 15 ug/ml adenine. P cells and all cells derived from it were 
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grown in EC 10 supplemented with azaserine, adenine and lx non-essential amino 
acids (EC 10AAN media). Selection for cells resistant to M tx was accomplished by 
the procedure of Alt et al., (1976). Briefly, approximately 2 to 5 x 105 cells in a 
100 mm plate were placed in Ec 10AAN medium which contained a two fold higher 
concentration of Mtx. After about two weeks, the plates contained approximately 
10 x 105 cells and the process was repeated after splitting the cells appropriately. 
Since thymidine, the substrate used by TK, is not added to EC 10AAN media, the 
absence or presence of TK activity should not affect the growth of cells under Mtx 
selective pressure. Cells were transformed by the procedure of Wigler et al. ( 1977) 
Enzyme assays 
TK activity was assayed by a modification of the procedure of Wigler 
(1977). The cells from one 100 mm plate near confluence were washed with cold 
PBS, scraped in 5 ml of cold PBS and pelleted. The pellet was resuspended in 150 ul 
of cold TK lysis buffer (lo mM Tris HCl pH 7.8, 10 mM KCl, l mM MgC12, lmM 
betamercaptoethanol and 20 uM thymidine). The cell suspension was frozen and 
rethawed four times in dry ice. To the solution was added 25 ul of 1.0 M KCl and 
the cells were spun for 10 min. in an eppendorf microfuge at 4°. On ice, 25 ul of 
reaction buffer (150 mM Tris HCl pH 7 .8, 20 mM MgC12, 25 mM KCl, l.5 mM 
betamercaptoethanol, 60 mM ATP and 7 5 uCi/ml 3H-thymidine 50 Ci/mmol) was 
added to 50 ul of cellular supernatant and mixed. Each sample was done in 
duplicate at several different lysate concentrations. As a negative control, lysis 
buffer plus KCl was used; neither BSA nor an extract made from L APRT- TK- cells 
gave a signal above the background value using lysis buffer alone. The rack 
containing the samples was placed in a 37° water bath for 30 minutes. The rack 
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was placed on ice and the reactions were terminated by spotting 50 ul on DE8 l 
disks. The disks were washed twice in 1 mM ammonium formate, once in water and 
once in ethanol for five minutes each with shaking at room temperature. The 
filters were dried, added to 10 ml hydrofluor and counted in a scintillation 
counter. Under these conditions, the reactions are linear for both amount of cell 
extract, from 5 ug to 150 ug total cell protein, and time, up to 90 minutes. The 
four samples usually gave values to within 10% of each other. The ATP 
concentration in the reaction mix was increased from 15 mM to 60 mM in order to 
keep the reaction linear for 90 minutes. Protein content was measured by the 
method of Bradford (1976). One unit is defined as that amount of enzyme required 
to convert 1 nmole thymidine into TMP in one minute. 
Hexokinase activity was measured as previously described (Walker and Parry, 
1966). 
Synthesis of RNA probes with SP6 polymerase 
A l.l kb Bgl 2 to Sma l fragment from the HSV TK gene was inserted into 
the Bgl 2 site of pSP6-4T such that sense TK sequences were transcribed and was 
therefore used as a probe for antisense TK RNA. A l.3 kb Eco R l to Sma 1 
fragment from the HSV TK gene was inserted between the Eco R l and the Sma l 
sites of pSP6-4T and was used as a probe for antisense RNA. Both vectors were 
linearized at their unique Eco Rl site prior to transcription. Synthesis of RNA 
probes by SP6 polymerase was done essentially as described (Melton et al. 1984). 
The transcription reaction did not contain bovine serum albumen. The RNA was 
labeled with 100 uCi of 32P-GTP diluted with unlabeled GTP at a final 
concentration of 38 uM. Other nucleotides were present at 500 uM. RNA was 
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separated from unincorporated nucleotides by sepharose G50 chromatography and 
DNA was removed by selecting for poly A+ RNA on an oligo-dT column (pSP6-4T 
contains poly A sequences). 
RNAse protection 
Total cellular RNA was prepared by the method of Chirgwin et al. (1979) 
except that the DNA in the initial lysate was sheared by sonication. Nuclear and 
cytoplasmic RNA was prepared by the method of Favaloro et al. ( 1980). Typically, 
3 x 108 cells were lysed in an initial volume of 10 ml and yielded l mg of total 
RNA. RNA was prepared quickly and was never left unfrozen longer than 
necessary. 
RNAse protection experiments were performed as described (Zinn et al., 
1984). To a sample of RNA to be tested (1 ug to 50 ug) was added 2 x 105 cpm of 
labeled probe (1 x 108 cpm/ug) and precipitated in 2 M ammonium acetate and l 
volume isopropyl alcohol. In the experiments described in figure 5, in which sense 
TK RNA was assayed in the presence of large amounts of antisense TK RNA, 5 x 
106 cpm of probe was used in order to insure a mass excess of probe. The dried 
RNA was dissolved in 30 ul of RNA hybridization buffer (80% formamide, 40 mM 
PIPES pH 6.4, 400 mM NaCl, l mM EDT A), melted at 85° for 10 minutes and 
hybridized at 45° overnight. A 300 ul addition of RNAse buffer (10 mM Tris Cl pH 
7.8,5 mM EDTA, 300 mM NaCl) containing 40 ug/ml RNAse A and 2 ug/ml RNAse 
Tl degraded unhybridized probe after incubation at 30° for 30 minutes. Control 
experiments showed that essentially all single stranded probe was digested using 
one tenth of the above RNAse concentration whereas the double stranded RNA was 
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resistant to thirty times the above RNAse concentration. The RNAses were 
inactivated by adding 10 ul of 20% SOS and 50 ug of proteinase K incubating at 37° 
for 15 minutes. The RNA was extracted with phenol and then precipitated three 
times from ammonium acetate as before after the addition of 25 ug of carrier 
tRNA. When the protected probe size was expected to be under l kb in length, the 
samples were dissolved in loading buffer (80% formamide, 40 mM Tris borate pH 
7.5), melted at 85° for 10 minutes and loaded onto 4% denaturing polyacrylamide 
gels (Maxam and Gilbert, 1980). Single stranded fragments were more susceptible 
to degradation by radiolysis than double stranded fragments. Therefore, for 
fragments greater than 1 kb in length, neutral polyacrylamide gels, using T AE 
buffer (50 mM Tris acetate, pH 7 .5, 1 mM EDT A), were used to analyze the 
undenatured RNA:RNA duplex. 
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Table 1. TK activity is diminished in cell lines that are 
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a. Concentration of Mtx (in uM) to which cells are resistant. 
b. Relative amount of TK activity normalized to P cells. The 
-2 
TK activity in P cells was 1.58 x 10 U/mg protein. 
c. number of experiments. 
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Table 2. TK activity in cell clones with amplified antisense 
genes 
a b c d 
cell line vector type Mtx TK hexokinase 
--------- ------ ----------
p NA c .01 1.0 
KT3-B-64 pMDKT3 p 64 .15 
KT3-B.1-64 pMDKT3 c 64 .78 
KT3-B.2-64 pMDKT3 c 64 .44 
KT3-B.3-64 pMDKT3 c 64 .47 
KT3-B.5-64 pMDKT3 c 64 • 1 1 1. 06 
KT3-B.6-64 pMDKT3 c 64 .16 1.03 
KT3-B.7-64 pMDKT3 c 64 .18 .94 
KT3-B.8-64 pMDKT3 c 64 .18 .84 
KT3-B.9-64 pMDKT3 c 64 .35 
a. C = clone. P = population 
b. Concentration of resistance to Mtx in uM. 
c. Relative amount of TK activity normalized to P cells. 




fig. 1. Restriction map of antisense vectors. The maps of pMD, pMDKT l, pMDKT2 
and pMDKT3 are shown. DHFR sequences are denoted by a white box. Antisense 
TK sequences are represented by a black box. The matallothionein promoter is 
indicated by an arrow. R =Eco Rl, S =Sac l, A= Ava l, H =Hind III, B =Barn Hl, 
P = Pst 1. 
fig. 2. TK activity in KT3 cells resistant to various levels of methotrexate. 
Resistance to given concentrations of methotrexate, in uM units, is plotted 
logarithmically along the x axis. Cell lines resistant to various levels of 
methotrexate were assayed for TK activity. The relative levels of TK activity are 
shown along they axis with parental TK+ cells (1.58xl0-2 U/mg protein) defined as 
having 100% activity. Assays were performed in triplicate and are accurate to 
within l 0%. KT3-B cells are represented by dark circles and KT3-D cells are 
represented by open circles. 
fig. 3. Antisense TK RNA analyzed by RNAse protection. Radiolabelled sense TK 
RNA was synthesized in vitro and hybridized to RNA samples. Unhybridized probe 
was digested with RNAse A and T 1. The protected probe, due to the presence of 
cellular antisense TK, was melted and fractionated on a 4% denaturing 
polyacrylamide gel. The cellular origin of the RNAs appear at the top. A. Total 
RNA (2.5 ug) from KT3-B-0.3, KT3-B-2 and KT3-B-64, representing cells before, 
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during and after methotrexate selection, was analyzed. A 50 fold exposure, to show 
the antisense RNA before amplification, is shown at the right. B. Starting from an 
equivalent number of KT3-B-64 cells, RNA was prepared from nuclear, cytoplasmic 
and total cellular fractions. Equal portions of each RNA fraction, corresponding to 
2.5 ug of total cellular RNA, was analyzed for the presence of antisense RNA. 
fig. 4. Detection of double stranded TK RNA. RNA was digested with RNAse A 
and T 1 leaving only double stranded RNA. The RNases were removed by digestion 
with proteinase Kand phenol extraction. The protected RNA was hybridized to 
radiolabelled antisense TK RNA synthesized in vitro. Unhybridized probe was 
digested with RNAse A and Tl. Protected probe, due to hybridization with the 
sense TK strand of the protected double stranded RNA, was melted and loaded on a 
4% sequencing gel. The origin of the RNAs appears at the top. Con. refers to a 
control experiment in which 50 ng of antisense TK RNA, synthesized in vitro, was 
added to P cells containing 100 ug total RNA immediately before RNA isolation. P 
refers to parental TK+ cells. The Con., P and KT3-64 lanes used 25 ug of RNA. 
From an equivalent number of cells, cytoplasmic and nuclear RNA from KT3-B-64 
cells was prepared. Equal fractions of each RNA preparation, corresponding to 25 
ug of total cellular RNA, was analyzed for the presence of double stranded RNA. 
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fig. 5. Sense TK RNA analyzed by RNAse protection. RNA was hybridized to 
radiolabelled antisense TK RNA synthesized in vitro. RNAse protection was 
performed as described in fig. 2. Origin of the RNA appears at the top. left: 12 ug 
of RNA was used. right: From an equivalent number of KT3-B-64 cells, RNA from 
nuclear, cytoplasmic and total cellular fractions was prepared. An equal portion of 
each RNA sample, corresponding to 12 ug of total cellular RNA, was analyzed for 
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